mitomycin has been researched along with Chronic Primary Open Angle Glaucoma in 320 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Comparison of the effect of mitomycin C (MMC) versus bevacizumab-methylcellulose mixture (BMM) on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure in patients with open-angle glaucoma was made." | 9.30 | Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study). ( Ghojazadeh, M; Latifi, A; Moghaddam, N; Mostafaei, A; Taheri, N, 2019) |
| "To compare the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C." | 9.10 | A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma. ( Kobayashi, H; Kobayashi, K; Okinami, S, 2003) |
| "To discuss the first case of mitomycin C (MMC) toxicity after XEN® gel stent implantation in a glaucoma patient, conducted using the XEN "air" technique with an ophthalmic viscosurgical device (OVD)." | 8.31 | A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient. ( Baeg, JY; Choi, HS; Lee, SH, 2023) |
| "The purpose of this study was to report a case of infective necrotizing scleritis following XEN Gel Stent with mitomycin-C." | 8.12 | Infective Necrotizing Scleritis After XEN Gel Stent With Mitomycin-C. ( Kingston, EJ; Lusthaus, JA; McCluskey, PJ; Raman, P; Symes, RJ; Zagora, SL, 2022) |
| "We performed retrospective analysis of 31 eyes with myopia that underwent canaloplasty modified with mitomycin C in a consecutive single-surgeon case series." | 8.12 | Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma? ( Dietlein, TS; Dooling, V; Lappas, A, 2022) |
| "2 mg/mL mitomycin C, either alone or in combination with cataract surgery." | 8.12 | Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022) |
| "To compare the short-term outcomes of combined phaco-emulsification with posterior chamber intra-ocular lens and mitomycin augmented trabeculectomy in patients with pseudo-exfoliation glaucoma (PXFG) versus primary open-angle glaucoma (POAG)." | 8.12 | Short-term surgical outcomes of twin-site combined phaco-emulsification and mitomycin-C augmented trabeculectomy in pseudo-exfoliation glaucoma versus primary open-angle glaucoma. ( Krishna, SM; Kumar, MR; Odayappan, A; Puthuran, GV; Senthilkumar, VA; Uduman, MS; Wijesinghe, HK, 2022) |
| "We report on a 56-year-old male with primary open-angle glaucoma who underwent mitomycin C augmented canaloplasty enabling filtration in the right eye after cataract surgery combined with a Schlemm's canal microstent 3 years previously." | 8.12 | Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation. ( Elksne, E; Mercieca, K; Prokosch-Willing, V, 2022) |
| "To analyse the morphological evolution of filtering blebs with anterior-segment OCT (AS-OCT) and its correlation with intraocular pressure after ab externo SIBS microshunt implantation with mitomycin C (MMC) during a 3-month follow-up period." | 8.12 | Anterior-segment optical coherence tomography of filtering blebs in the early postoperative period of ab externo SIBS microshunt implantation with mitomycin C: Morphological analysis and correlation with intraocular pressure reduction. ( Gómez de Liaño, R; Ibarz Barberá, M; Morales Fernández, L; Tañá Rivero, P; Teus, MA, 2022) |
| "The XEN® gel stent in combination with mitomycin C is a therapeutic option for difficult to adjust secondary glaucoma following intravitreal anti-VEGF therapy." | 8.02 | [Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C]. ( Bedar, MS; Kellner, U, 2021) |
| "To compare the outcomes of Aurolab aqueous drainage implant (AADI; Aurolab) placement and trabeculectomy with mitomycin C (MMC) in patients with glaucoma secondary to aniridia." | 8.02 | Outcomes of Glaucoma Drainage Device Implantation and Trabeculectomy With Mitomycin C in Glaucoma Secondary to Aniridia. ( Durai, I; Gedde, SJ; Krishnadas, SR; Pallamparthy, S; Palmberg, P; Puthuran, GV; Robin, AL; Uduman, MS; Wijesinghe, HK, 2021) |
| " It was the aim of this study to investigate the therapeutic success of Xen45 gel stents as a stand-alone technique (Xen) and combined with cataract surgery (XenPhaco), and with antimetabolites (mitomycin C, MMC) in open-angle glaucoma patients." | 8.02 | Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients. ( Denkel, L; Hohberger, B; Lämmer, R, 2021) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG) patients." | 7.77 | Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. ( Ollikainen, ML; Puustjärvi, TJ; Rekonen, PK; Teräsvirta, ME; Uusitalo, HM, 2011) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in patients with primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG)." | 7.76 | Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study. ( Ollikainen, M; Puustjärvi, T; Rekonen, P; Teräsvirta, M; Uusitalo, H, 2010) |
| "To investigate the relationship between intrascleral bleb height and intraocular pressure (IOP) following deep sclerectomy with collagen implant (DSCI) and mitomycin C (MMC) in eyes with clinically flat blebs." | 7.76 | Postoperative IOP is related to intrascleral bleb height in eyes with clinically flat blebs following deep sclerectomy with collagen implant and mitomycin. ( Mavrakanas, N; Mendrinos, E; Shaarawy, T, 2010) |
| "To analyse clinical outcomes of trabeculectomy with mitomycin C (MMC) in eyes with uveitic glaucoma (UG) with inactive uveitis and compare them to those in eyes with primary open-angle glaucoma (POAG)." | 7.75 | Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. ( Araie, M; Kaburaki, T; Kawashima, H; Koshino, T; Numaga, J; Shirato, S; Tomidokoro, A, 2009) |
| "To evaluate the short-term effect of trabeculectomy with adjunctive mitomycin-C (MMC) on corneal astigmatism and axial length." | 7.71 | Short-term effect of mitomycin-C augmented trabeculectomy on axial length and corneal astigmatism. ( Kim, HB; Kook, MS; Lee, SU, 2001) |
| "To evaluate acute retinal vein occlusion as a potential complication of trabeculectomy with mitomycin C in cases of advanced glaucoma." | 7.69 | Retinal vein occlusion after trabeculectomy with mitomycin C. ( Dev, S; Herndon, L; Shields, MB, 1996) |
| "The mean intraocular pressures were significantly (P < ." | 6.69 | Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C. ( Bendel, RE; Hughes, BA; Juzych, MS; Kim, C; Lemon, LC; Shin, DH, 1998) |
| "These include young patients, those with pigmentary glaucoma, secondary glaucoma, angle recession glaucoma, aphakic or pseudophakic glaucoma, and patients requiring reoperation." | 6.67 | Intraoperative mitomycin C in complicated glaucomas. ( Dogra, A; Kaur, J; Singh, G, 1993) |
| "Comparison of the effect of mitomycin C (MMC) versus bevacizumab-methylcellulose mixture (BMM) on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure in patients with open-angle glaucoma was made." | 5.30 | Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study). ( Ghojazadeh, M; Latifi, A; Moghaddam, N; Mostafaei, A; Taheri, N, 2019) |
| "To evaluate the intraocular pressure-lowering effect of sutureless scleral tunnel trabeculectomy with Mitomycin-C (MMC) compared to the standard trabeculectomy with MMC in patients with primary open angle glaucoma (POAG)." | 5.27 | Sutureless Scleral Tunnel Trabeculectomy: Evaluation of Feasibility and Effectiveness versus Conventional Trabeculectomy for Management of Primary Open Angle Glaucoma. ( Elsawy, MF; Khairy, HA; Said-Ahmed, K, 2018) |
| "We assessed bleb morphology and the intraocular pressure (IOP)-lowering effect of trabeculectomy with ologen compared to mitomycin C (MMC) in juvenile open-angle glaucoma (JOAG)." | 5.24 | Trabeculectomy with Ologen versus Mitomycin C in Juvenile Open-Angle Glaucoma: A 1-Year Study. ( Abdelhakim, MASE; El-Saied, HMA; El-Sayyad, F, 2017) |
| "To evaluate the intraocular pressure (IOP)-lowering effect of trabeculectomy with the use of amniotic membrane transplant (AMT) compared with the standard trabeculectomy with Mitomycin-C (MMC) in patients with primary open-angle glaucoma." | 5.20 | Trabeculectomy With Mitomycin-C Versus Trabeculectomy With Amniotic Membrane Transplant: A Medium-term Randomized, Controlled Trial. ( Elsawy, MF; Khairy, HA, 2015) |
| "To compare the long-term effects of low-dosage mitomycin C (MMC) in both deep sclerectomy (DSMMC) and trabeculectomy (TPMMC) on intraocular pressure (IOP)." | 5.13 | Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up. ( Casuccio, A; Cillino, G; Cillino, S; Di Pace, F; Lodato, G, 2008) |
| "To compare the intraocular pressure (IOP)-lowering effect of combined viscocanalostomy and phacoemulsification and combined trabeculectomy and phacoemulsification with mitomycin C in eyes with primary open-angle glaucoma." | 5.12 | Randomized comparison of the intraocular pressure-lowering effect of phacoviscocanalostomy and phacotrabeculectomy. ( Kobayashi, H; Kobayashi, K, 2007) |
| "To compare the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C." | 5.10 | A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma. ( Kobayashi, H; Kobayashi, K; Okinami, S, 2003) |
| "To evaluate the effect of ab-interno goniotrabeculotomy (AIGT) on the intraocular pressure (IOP) in adult patients with primary open-angle glaucoma (POAG), compared with the effects of mitomycin C trabeculectomy (MT)." | 5.09 | Ab-interno goniotrabeculotomy versus mitomycin C trabeculectomy for adult open-angle glaucoma: a 2-year randomized clinical trial. ( Hitchings, RA; Quaranta, CA; Quaranta, L, 1999) |
| "Seventy-eight eyes of 78 patients with primary open-angle glaucoma with visually symptomatic cataracts and no previous incisional surgery were randomized to receive either no mitomycin C or a subconjunctival application of 1-, 3-, or 5-minute mitomycin C (0." | 5.08 | Adjunctive subconjunctival mitomycin C in glaucoma triple procedure. ( Hughes, BA; Juzych, MS; Kim, C; Reed, SY; Shin, DH; Simone, PA; Song, MS, 1995) |
| "To establish the long-term, dose-response relationship between the concentration of and duration of exposure to mitomycin to a decrease in intraocular pressure (IOP) and fewer complications." | 5.08 | A long-term dose-response study of mitomycin in glaucoma filtration surgery. ( Bhatnagar, R; Katz, JD; Krishnadas, R; Ramakrishnan, R; Robin, AL; Selvaraj, S; Skuta, GL; Smith, SD, 1997) |
| "In the diclofenac group (n = 14), the preoperative intraocular pressure of 30." | 5.08 | The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C. ( Cate, EA; Dubiner, HB; Kent, AR; Mundorf, TK; Stewart, JA; Stewart, WC; Whitaker, R, 1998) |
| "To compare the intraocular pressure and hypotony outcomes of primary phakic trabeculectomies with no mitomycin C (MMC), shorter MMC, and longer MMC exposure." | 5.08 | Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C. ( Ginde, SA; Kim, C; Kim, YY; Kupin, TH; Lee, D; Ren, J; Sexton, RM; Shin, DH, 1998) |
| "We retrospectively reviewed primary glaucoma patients who underwent mitomycin C-augmented trabeculectomy and completed 2 years of follow-up." | 4.31 | Two-Year Outcomes of Trabeculectomy and Phacotrabeculectomy in Primary Open Angle Versus Primary Angle Closure Glaucoma. ( Chansangpetch, S; Itthipanichpong, R; Manassakorn, A; Ratanawongphaibul, K; Rojanapongpun, P; Tantisevi, V; Winuntamalakul, Y, 2023) |
| " To assess the influence of cataract surgery following TE, eyes which underwent cataract surgery at least 6 months after TE were matched 1:3 by sex and age to eyes who did not undergo cataract surgery during the follow-up period." | 4.31 | Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study. ( Hoffmann, EM; Kianusch, K; Pfeiffer, N; Schuster, AK; Stingl, J; Wagner, FM, 2023) |
| "To evaluate the efficacy and safety of the Preserflo MicroShunt with mitomycin C in patients with complicated glaucoma." | 4.31 | One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma. ( Erokhina, M; Haus, A; Seuthe, AM; Szurman, P, 2023) |
| "Trabeculectomy with mitomycin C was the most common primary surgery performed in Thai patients with JOAG, and successfully reduced intraocular pressure without significant complications." | 4.31 | Treatment Outcomes for Juvenile Open Angle Glaucoma in Thailand. ( Annopawong, K; Friedman, DS; Seresirikachorn, K; Thiamthat, W; Vu, DM; Wanichwecharungruang, B, 2023) |
| "To discuss the first case of mitomycin C (MMC) toxicity after XEN® gel stent implantation in a glaucoma patient, conducted using the XEN "air" technique with an ophthalmic viscosurgical device (OVD)." | 4.31 | A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient. ( Baeg, JY; Choi, HS; Lee, SH, 2023) |
| "The purpose of this study was to report a case of infective necrotizing scleritis following XEN Gel Stent with mitomycin-C." | 4.12 | Infective Necrotizing Scleritis After XEN Gel Stent With Mitomycin-C. ( Kingston, EJ; Lusthaus, JA; McCluskey, PJ; Raman, P; Symes, RJ; Zagora, SL, 2022) |
| "We performed retrospective analysis of 31 eyes with myopia that underwent canaloplasty modified with mitomycin C in a consecutive single-surgeon case series." | 4.12 | Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma? ( Dietlein, TS; Dooling, V; Lappas, A, 2022) |
| "2 mg/mL mitomycin C, either alone or in combination with cataract surgery." | 4.12 | Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022) |
| "To compare the short-term outcomes of combined phaco-emulsification with posterior chamber intra-ocular lens and mitomycin augmented trabeculectomy in patients with pseudo-exfoliation glaucoma (PXFG) versus primary open-angle glaucoma (POAG)." | 4.12 | Short-term surgical outcomes of twin-site combined phaco-emulsification and mitomycin-C augmented trabeculectomy in pseudo-exfoliation glaucoma versus primary open-angle glaucoma. ( Krishna, SM; Kumar, MR; Odayappan, A; Puthuran, GV; Senthilkumar, VA; Uduman, MS; Wijesinghe, HK, 2022) |
| "We report on a 56-year-old male with primary open-angle glaucoma who underwent mitomycin C augmented canaloplasty enabling filtration in the right eye after cataract surgery combined with a Schlemm's canal microstent 3 years previously." | 4.12 | Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation. ( Elksne, E; Mercieca, K; Prokosch-Willing, V, 2022) |
| "To analyse the morphological evolution of filtering blebs with anterior-segment OCT (AS-OCT) and its correlation with intraocular pressure after ab externo SIBS microshunt implantation with mitomycin C (MMC) during a 3-month follow-up period." | 4.12 | Anterior-segment optical coherence tomography of filtering blebs in the early postoperative period of ab externo SIBS microshunt implantation with mitomycin C: Morphological analysis and correlation with intraocular pressure reduction. ( Gómez de Liaño, R; Ibarz Barberá, M; Morales Fernández, L; Tañá Rivero, P; Teus, MA, 2022) |
| "Sixty eyes of 60 patients complaining of primary open angle glaucoma and cataract, undergoing phaco-trabeculectomy, were distributed into three groups: group I: surgery was augmented with mitomycin C, group II with porcine extracellular matrix, and group III with porcine extracellular matrix combined with low dose mitomycin C." | 4.02 | The role of mitomycin C and porcine extracellular matrix in phacotrabeculectomy. ( Hamdi, IM; Hamdi, MM, 2021) |
| "The XEN® gel stent in combination with mitomycin C is a therapeutic option for difficult to adjust secondary glaucoma following intravitreal anti-VEGF therapy." | 4.02 | [Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C]. ( Bedar, MS; Kellner, U, 2021) |
| "To compare the outcomes of Aurolab aqueous drainage implant (AADI; Aurolab) placement and trabeculectomy with mitomycin C (MMC) in patients with glaucoma secondary to aniridia." | 4.02 | Outcomes of Glaucoma Drainage Device Implantation and Trabeculectomy With Mitomycin C in Glaucoma Secondary to Aniridia. ( Durai, I; Gedde, SJ; Krishnadas, SR; Pallamparthy, S; Palmberg, P; Puthuran, GV; Robin, AL; Uduman, MS; Wijesinghe, HK, 2021) |
| " It was the aim of this study to investigate the therapeutic success of Xen45 gel stents as a stand-alone technique (Xen) and combined with cataract surgery (XenPhaco), and with antimetabolites (mitomycin C, MMC) in open-angle glaucoma patients." | 4.02 | Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients. ( Denkel, L; Hohberger, B; Lämmer, R, 2021) |
| "8% of eyes (n=10) required at least 1 mitomycin C (MMC)-enhanced needling revision to maintain their target intraocular pressure." | 3.96 | Impact of Phacoemulsification Combined with XEN Gel Stent Implantation on Corneal Endothelial Cell Density: 2-Year Results. ( Bravetti, GE; Gillmann, K; Mansouri, K; Mermoud, A; Rao, HL, 2020) |
| "Phacotrabeculectomy with adjunctive mitomycin C is a good option for the management of coexisting cataract and glaucoma." | 3.91 | Phacotrabeculectomy in Eyes With Uveitic Glaucoma: A Retrospective Case-Control Study. ( Balekudaru, S; Biswas, J; Ganesh, SK; George, AE; George, R; Lingam, V; Wadke, V, 2019) |
| "PRéCIS:: The present study suggests that immediate trabeculectomy with mitomycin C (MMC) may be performed as a safe and effective intervention in the management of refractory ocular hypertension (OHT)/glaucoma in patients with bilateral acute iris transillumination (BAIT)." | 3.91 | Long-term Results of Trabeculectomy With Mitomycin-C in Patients With Bilateral Acute Iris Transillumination. ( Altan, C; Basarir, B; Bayraktar, S; Izgi, B; Oray, M; Tugal-Tutkun, I, 2019) |
| "Primary Trabeculectomy with Mitomycin C is a safe and effective means of controlling Intraocular Pressure in both groups with good success and low rates of sight-threatening complications." | 3.91 | Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle closure glaucoma. ( Kadar, MA; Kanduri, S; Maheshwari, D; Pillai, MR; Ramakrishnan, R, 2019) |
| " Before the surgery, his intraocular pressure (IOP) was 20 to 22 mm Hg with bimatoprost 0." | 3.85 | Bimatoprost-induced late-onset choroidal detachment after trabeculectomy: A case report and review of the literature. ( Kiuchi, Y; Nakakura, S; Noguchi, A; Tabuchi, H, 2017) |
| "To evaluate the influence of phacoemulsification on intraocular pressure (IOP) control and survival of mitomycin C (MMC)-enhanced trabeculectomy in uveitic glaucoma (UG)." | 3.85 | The Influence of Phacoemulsification on Intraocular Pressure Control and Trabeculectomy Survival in Uveitic Glaucoma. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2017) |
| "Consecutive prospective case series study to examine the 6-month outcome of 106 eyes [primary open-angle glaucoma (OAG), exfoliation glaucoma (XFG), and inflammatory glaucoma (ING)] that underwent TLE with mitomycin C performed by a single surgeon from September 2009 to September 2010 at Tokyo University Hospital." | 3.81 | Targeting a low-teen intraocular pressure by trabeculectomy with a fornix-based conjunctival flap: continuous Japanese case series by a single surgeon. ( Aihara, M; Aoyama, Y; Murata, H, 2015) |
| "To determine the occurrence of intraoperative and postoperative complications up to three years after primary phacotrabeculectomy with intraoperative use of Mitomycin C (MMC) in primary open angle (POAG) and primary angle closure glaucoma (PACG) patients, and the effect of postoperative complications on surgical outcome." | 3.81 | Complications and outcomes of primary phacotrabeculectomy with mitomycin C in a multi-ethnic asian population. ( Aquino, MC; Chen, DZ; Chew, P; Koh, V; Sng, C, 2015) |
| "The goal of this study was to identify the early postoperative intraocular pressure (IOP) that predicts low pressure control after a trabeculectomy with mitomycin C." | 3.80 | Using the early postoperative intraocular pressure to predict pressure control after a trabeculectomy. ( Akita, T; Kiuchi, Y; Okimoto, S; Tanaka, J, 2014) |
| "Twelve filtering blebs of 8 patients were included: 4 cases of trabeculectomy without mitomycin C (MMC), 6 cases of trabeculectomy with MMC, and 2 cases of non-penetrating glaucoma surgery." | 3.80 | [Evaluation of conjunctival epithelium of filtering blebs by impression cytology]. ( Buetas, P; González, S; López, S; Matias-Guiu, X; Muniesa, MJ; Sánchez, C, 2014) |
| "The medical records of patients with primary open-angle glaucoma or exfoliation glaucoma who had trabeculectomy with mitomycin-C were reviewed." | 3.78 | Impact of phacoemulsification on failure of trabeculectomy with mitomycin-C. ( Awai-Kasaoka, N; Inatani, M; Inoue, T; Kawaguchi, A; Ogata-Iwao, M; Takihara, Y; Tanihara, H, 2012) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG) patients." | 3.77 | Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. ( Ollikainen, ML; Puustjärvi, TJ; Rekonen, PK; Teräsvirta, ME; Uusitalo, HM, 2011) |
| "Pre- and postsurgical IOPs at 6 months were compared in one eye of each of 789 subjects with primary open-angle glaucoma, pseudoexfoliation glaucoma, or ocular hypertension who underwent trabeculectomy with adjunctive mitomycin C alone (Lectomy-MMC) (n = 145), phaco-viscocanalostomy (Phaco-VCS) (n = 320), phaco-trabeculotomy ab externo (Phaco-lotomy) (n = 116), or phacoemulsification aspiration and intraocular lens implantation alone (PEA+IOL) (n = 208)." | 3.77 | Different modes of intraocular pressure reduction after three different nonfiltering surgeries and trabeculectomy. ( Chihara, E; Hayashi, K, 2011) |
| "Patients with open-angle glaucoma who underwent either canaloplasty or trabeculectomy with mitomycin C to control the intraocular pressure (IOP) between January 2007 and December 2008 were included." | 3.77 | Comparison of surgical outcomes between canaloplasty and trabeculectomy at 12 months' follow-up. ( Ayyala, RS; Chaudhry, AL; Okogbaa, CB; Zurakowski, D, 2011) |
| "We report on a patient with an overhanging bleb several years following trabeculectomy surgery with mitomycin C." | 3.77 | Dramatic dysesthetic overhanging bleb. ( Kapoor, KG; Syed, MF, 2011) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in patients with primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG)." | 3.76 | Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study. ( Ollikainen, M; Puustjärvi, T; Rekonen, P; Teräsvirta, M; Uusitalo, H, 2010) |
| "Two eyes of 2 patients status postfornix-based trabeculectomy with mitomycin C were found to have symptomatic circumferential blebs." | 3.76 | Application of handheld cautery for reduction of symptomatic circumferential trabeculectomy blebs. ( Albano, M; Schwartz, AL, 2010) |
| "To investigate the relationship between intrascleral bleb height and intraocular pressure (IOP) following deep sclerectomy with collagen implant (DSCI) and mitomycin C (MMC) in eyes with clinically flat blebs." | 3.76 | Postoperative IOP is related to intrascleral bleb height in eyes with clinically flat blebs following deep sclerectomy with collagen implant and mitomycin. ( Mavrakanas, N; Mendrinos, E; Shaarawy, T, 2010) |
| "To analyse clinical outcomes of trabeculectomy with mitomycin C (MMC) in eyes with uveitic glaucoma (UG) with inactive uveitis and compare them to those in eyes with primary open-angle glaucoma (POAG)." | 3.75 | Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. ( Araie, M; Kaburaki, T; Kawashima, H; Koshino, T; Numaga, J; Shirato, S; Tomidokoro, A, 2009) |
| "To evaluate whether patients who have undergone trabeculectomy with mitomycin C have a different intraocular pressure (IOP) response profile after the water drinking test (WDT) from that of patients who are medically managed with a similar baseline IOP and level of visual field (VF) damage." | 3.74 | Medically controlled glaucoma patients show greater increase in intraocular pressure than surgically controlled patients with the water drinking test. ( Danesh-Meyer, HV; Gamble, GD; Papchenko, T; Tan, YW, 2008) |
| "To evaluate long-term tonometric outcomes of trabeculectomy with adjunctive mitomycin C (MMC) and its efficacy in achieving a range of intraocular pressures (IOP) in phakic patients with open-angle glaucoma." | 3.73 | Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. ( Caprioli, J; Fontana, H; Lumba, J; Nouri-Mahdavi, K; Ralli, M, 2006) |
| "To determine the long-term intraocular pressure (IOP) control and postoperative complications after initial trabeculectomy with use of mitomycin C (MMC) in patients with primary open-angle glaucoma (POAG)." | 3.73 | Long-term follow-up of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients. ( Araie, M; Chen, YN; Shigeeda, T; Shirato, S; Tomidokoro, A, 2006) |
| "To compare the efficacy and safety of fornix-based and limbus-based conjunctival flaps of phacotrabeculectomy with mitomycin C in patients with primary open angle glaucoma and cataract." | 3.72 | Fornix vs limbus based flap in phacotrabeculetomy with mitomycin C: prospective study. ( Bencić, G; Bojić, L; Mandić, Z; Zorić Geber, M, 2004) |
| "To evaluate the short-term effect of trabeculectomy with adjunctive mitomycin-C (MMC) on corneal astigmatism and axial length." | 3.71 | Short-term effect of mitomycin-C augmented trabeculectomy on axial length and corneal astigmatism. ( Kim, HB; Kook, MS; Lee, SU, 2001) |
| "After trabeculectomy with mitomycin C, extremely low intraocular pressure (IOP) with excess filtration may cause hypotonous maculopathy in the early postoperative period." | 3.71 | Autologous blood injection for marked overfiltration early after trabeculectomy with mitomycin C. ( Jian, K; Masumoto, M; Mishima, HK; Mochizuki, H; Okada, K; Okada, M; Tsukamoto, H, 2001) |
| "To evaluate acute retinal vein occlusion as a potential complication of trabeculectomy with mitomycin C in cases of advanced glaucoma." | 3.69 | Retinal vein occlusion after trabeculectomy with mitomycin C. ( Dev, S; Herndon, L; Shields, MB, 1996) |
| "The authors studied the effect of topical mitomycin-C administration on the maintenance of filter function and intraocular pressure (IOP) following laser sclerostomy." | 3.69 | Mitomycin-C in laser sclerostomy: benefit and complications. ( Birngruber, R; Dröge, G; Schmidt-Erfurth, U; Wetzel, W, 1997) |
| "The revision of a failed filtering bleb using mitomycin C was performed in 40 eyes (28 eyes with primary open angle glaucoma and 12 eyes with secondary open angle glaucoma) in which the previous trabeculectomy using 5-fluorouracil had failed to control intraocular pressure (IOP)." | 3.69 | [Surgical revision of failed filtering bleb with mitomycin C]. ( Hara, T; Shirato, S, 1997) |
| "Astigmatism was measured using objective refraction and corneal topography, IOP and visual acuity were also assessed." | 2.90 | Suture Removal After Trabeculectomy With Fornix-based Conjunctival Flap Leads to Faster Visual Recovery but Not Reduced Astigmatism. ( Hoffmann, E; Laspas, P; Leichsenring, V; Pfeiffer, N; Preussner, R; Wahl, J, 2019) |
| "Patients with primary open angle glaucoma, not controlled with medication, were selected from the outpatient department." | 2.87 | Comparison of Mean Corneal Endothelial Cell Loss after Trabeculectomy with and without Mitomycin C. ( Ahmed, N; Amjad, A; Shaheer, M, 2018) |
| "Mitomycin C was used in 25 procedures (83." | 2.77 | CO2 laser-assisted sclerectomy surgery, part II: multicenter clinical preliminary study. ( Assia, EI; Degani, J; Geffen, N; Ton, Y, 2012) |
| "In this pilot study with a small number of subjects, short-term outcomes suggest that subconjunctival bevacizumab is equally effective in reducing intraocular pressure with a better safety profile compared with MMC in the dosing schedule studied." | 2.77 | Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial. ( Ravindran, RD; Sengupta, S; Venkatesh, R, 2012) |
| "The primary endpoint measured was bleb morphology and vascularity using the Moorfields Bleb Grading System." | 2.75 | Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study. ( Kahook, MY, 2010) |
| "The filtering blebs were evaluated clinically and with SL-OCT on day 1 and 1, 2, 4 and 12 weeks following surgery." | 2.73 | A pilot study on slit lamp-adapted optical coherence tomography imaging of trabeculectomy filtering blebs. ( Keunen, JE; Klevering, BJ; Theelen, T; Wesseling, P, 2007) |
| "Mean intraocular pressure was significantly lower in both groups." | 2.72 | Estimation of risk-benefit ratio and comparison of post-operative efficacy results between trabeculectomy and canaloplasty. ( Fili, S; Gatzioufas, Z; Kohlhaas, M; Perdikakis, G; Vastardis, I, 2021) |
| "The intraocular pressure was significantly decreased by 7." | 2.70 | Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. ( Christodoulakis, EV; Kozobolis, VP; Pallikaris, IG; Tzanakis, N; Zacharopoulos, I, 2002) |
| "The mean intraocular pressures were significantly (P < ." | 2.69 | Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C. ( Bendel, RE; Hughes, BA; Juzych, MS; Kim, C; Lemon, LC; Shin, DH, 1998) |
| "41 cases 68 eyes with late stage of primary open angle glaucoma (POAG) were randomly studied by treatment with IFN alpha-2b or MMC following trabeculectomy, each group consisting of 34 eyes." | 2.69 | [A clinical comparative study of interferon alpha-2b with mitomycin C applied in glaucoma filtering operation]. ( Ge, J; Peng, D; Ye, T; Zhang, X; Zhou, W, 2000) |
| "Mitomycin C-treated eyes received an average of 0." | 2.68 | 5-Fluorouracil and mitomycin C in pseudophakic patients. ( Belkin, JK; Lamping, KA, 1995) |
| "Mitomycin was applied for 5 minutes only once during trabeculectomy." | 2.67 | Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. ( Kawase, K; Kitazawa, Y; Suemori-Matsushita, H; Yamamoto, T, 1993) |
| "These include young patients, those with pigmentary glaucoma, secondary glaucoma, angle recession glaucoma, aphakic or pseudophakic glaucoma, and patients requiring reoperation." | 2.67 | Intraoperative mitomycin C in complicated glaucomas. ( Dogra, A; Kaur, J; Singh, G, 1993) |
| " The optimum route of administration and dosing regimen of anti-VEGF antibodies and their positioning in comparison with 5-fluorouracil and mitomycin C are uncertain." | 2.47 | Anti--vascular endothelial growth factor therapy in glaucoma filtration surgery. ( Barton, K; Mathew, R, 2011) |
| " New anti-glaucoma drugs, latanoprost and nipradilol, have been shown to effect a reduction in IOP equal to that achieved with the equivalent dosage of timolol, with no adverse systemic side effects." | 2.39 | [Current topics in glaucoma]. ( Masuda, K, 1996) |
| " The history obtained directly from the surgeon revealed that MMC dosing was 0." | 1.72 | Acute iris toxicity following bilateral gel stent implantation with mitomycin-C and intracameral moxifloxacin January consultation #1. ( Liaboe, C; Samuelson, TW, 2022) |
| "Mitomycin C (MMC) was used in 54,8% of the cases, collagen matrix (Ologen®, Aeon Astron Corporation, Taipei, Taiwan) was used alone in 8." | 1.72 | Survey of glaucoma surgical preferences among glaucoma specialists in Spain. ( Balboa Miró, M; Botella García, J; Duch, S; Loscos Arenas, J; Moreno-Montañés, J; Romera Romero, P, 2022) |
| "Eyes with primary open angle glaucoma (OAG), secondary OAG or pseudophakic primary angle closure glaucoma (PACG) were included." | 1.72 | Outcomes of XEN45 gel stent using posterior small incision sub-tenon ab interno insertion (Semi-open) technique. ( Ang, GS; Chung, IY; Kong, YXG, 2022) |
| "To evaluate the effectiveness of repeat trabeculectomy with Mitomycin C (MMC) in isolation or combined with phacoemulsification, and to identify risk factors for failure over 1 year." | 1.62 | Outcome of repeat trabeculectomy with mitomycin C in isolation or combined with phacoemulsification. ( George, R; Jagannathan, J; Shantha, B; Vijaya, L, 2021) |
| "Low postoperative complications were recorded." | 1.56 | Penetrating deep sclerectomy in primary open-angle and pseudoexfoliative glaucoma. ( Kalogianni, E; Kozobolis, V; Sideroudi, H, 2020) |
| "Mean intraocular pressure was significantly reduced from 21." | 1.51 | One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients. ( Arrieta-Los Santos, A; Chacón-González, M; Del Río Mayor, JL; Ibáñez-Muñoz, A; Lizuain-Abadía, ME; Rúa-Galisteo, O; Soto-Biforcos, VS, 2019) |
| "However, extensive subretinal hemorrhage was observed, and the patient underwent pneumatic displacement and pars plana vitrectomy to remove the hemorrhage." | 1.48 | Extensive Submacular Hemorrhage After Trabeculectomy With Mitomycin C. ( Ahn, JY; Chung, IY; Han, YS; Kim, GN; Kim, SJ; Park, JM; Seo, SW; Shin, MH; Yoo, JM, 2018) |
| "Main postoperative complications were transient: 4 eyes with seidel phenomenon at 24 hours (10." | 1.46 | Two-year Results After Deep Sclerectomy With Nonabsorbable Uveoscleral Implant (Esnoper-Clip): Surgical Area Analysis Using Anterior Segment Optical Coherence Tomography. ( Castellvi-Manent, J; Loscos-Arenas, J; Moll-Udina, A; Romanic-Bubalo, N; Romera-Romero, P; Valldeperas, X, 2017) |
| "To determine the long-term outcomes of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C (MMC) for primary angle-closure glaucoma (PACG) and primary open-angle glaucoma (POAG) in an Asian population." | 1.46 | Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population. ( Aduan, J; Aquino, CM; Chee, LS; Chen, D; Chew, P; Koh, V; Sng, C, 2017) |
| "This condition may manifest as multiple retinal hemorrhages, edema of the optic disc, macular edema, or a sudden decrease in visual acuity postoperatively." | 1.43 | Consecutive bilateral decompression retinopathy after mitomycin C trabeculectomy: a case report. ( Figueiredo, ARM; Menéres, MJFDS; Sampaio, IC; Spaeth, GL, 2016) |
| "Three procedures (6%) had intraoperative complications (2 iris prolapses, 1 subconjunctival hemorrhage)." | 1.43 | Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies. ( Ang, GS; Meagher, P; Wang, BZ, 2016) |
| "To report the 5-year incidence of visual impairment after mitomycin C-augmented trabeculectomy (MMC trabeculectomy) and the risk factors for visual impairment." | 1.43 | Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C. ( Araie, M; Chiba, T; Kashiwagi, K; Kogure, S; Kuwayama, Y; Mabuchi, F; Yamamoto, T, 2016) |
| "To determine the efficacy of safe surgery system trabeculectomy combined with manual small incision cataract surgery/phacoemulsification in primary glaucoma coexistent with cataract." | 1.42 | Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction. ( Agashe, A; Khandelwal, R; Khandelwal, RR; Majumdar, M; Raje, D; Rathi, A, 2015) |
| "Forty-eight eyes of 41 patients with open angle glaucoma (OAG), who underwent DS with supraciliary hema implant (Esnoper(®) V-2000), were included in this study." | 1.42 | Deep sclerectomy with supraciliary hema implant (Esnoper® V-2000): results and complications. ( de la Cámara, J; Langhor, K; Langohr, K; Loscos, J; Parera, À; Romera, P; Sabala, A; Valldeperas, X, 2015) |
| "The majority of patients with juvenile idiopathic arthritis-related uveitic glaucoma require surgery to control intraocular pressure." | 1.42 | Potential Effect of Tumor Necrosis Factor Inhibitors on Trabeculectomy With Mitomycin C for Patients With Juvenile Idiopathic Arthritis-Related Uveitic Glaucoma: A Retrospective Analysis. ( Kivelä, T; Kotaniemi, K; Leinonen, S; Majander, A, 2015) |
| "Mitomycin-c (MMC) was used in 75 (77." | 1.40 | Can intraoperative intraocular pressure during primary trabeculectomy predict early postoperative pressure? ( Chang, X; Cui, HY; Fan, SJ; He, Y; Huang, Y; Li, SZ; Liang, YB; Liu, LR; Meng, HL; Rong, SS; Thomas, R; Wang, NL; Wang, R; Zhang, ZH, 2014) |
| "Only pseudophakia was significantly associated with outcome in the multivariable analysis for criterion A (relative risk, 9." | 1.40 | Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study. ( Inatani, M; Inoue, T; Iwao, K; Kawai, M; Ogata-Iwao, M; Takihara, Y; Tanihara, H, 2014) |
| " Low dosage MMC was applied beneath the superficial scleral flap before dissecting the second, deep scleral flap and accessing Schlemm canal." | 1.39 | Canaloplasty with intraoperative low dosage mitomycin C: a retrospective case series. ( Barnebey, HS, 2013) |
| "the Wuerzburg bleb classification score (WBCS) aims at an objective and standardized assessment of the developing filtering bleb after trabeculectomy, in order to detect and treat bleb scarring at the earliest possible stage of development." | 1.37 | The prognostic value of the wuerzburg bleb classification score for the outcome of trabeculectomy. ( Ellinger, P; Grehn, F; Guthoff, R; Kann, G; Klink, J; Klink, T, 2011) |
| "Mean intraocular pressure was significantly reduced from 15." | 1.37 | Effect of trabeculectomy on ocular and corneal higher order aberrations. ( Amano, S; Araie, M; Fukuoka, S; Honda, N; Mimura, T; Usui, T, 2011) |
| "Mean intraocular pressure was 28." | 1.37 | Needling augmented with topical application of mitomycin C for management of bleb failure. ( Abd El Hameed, M; Ghoneim, EM, 2011) |
| "Postoperative complications were: ocular hypotony (1 case), bleb fibrosis (2 cases), bleb-related endophthalmitis (1 case)." | 1.36 | [Non-pentrating deep sclerectomy--between safety and efficacy]. ( Cantemir, A; Chiseliţă, D; Ilieş, I, 2010) |
| "Visualization of filtering bleb structure in vivo is an objective and helpful method of evaluation of functioning status following trabeculectomy." | 1.35 | [Evaluation on the cellular level the filtering bleb following trabeculectomy, using the HRT II Cornea Module]. ( Jurowska-Liput, J; Krzyzanowska, P; Nizankowska, MH; Szelepin, Ł, 2008) |
| "Within this group, blebs were classified into three different categories according to their optical coherence tomography pattern: type A (featuring a thick wall and a single large fluid-filled space), type B (featuring a thin wall and multiple large fluid-filled spaces) and type C (featuring multiple, irregular and flattened fluid-filled spaces)." | 1.33 | Filtering blebs imaging by optical coherence tomography. ( Barboni, P; Savini, G; Zanini, M, 2005) |
| "A case of early-onset sclerolimbal ectasia following low-dose topical mitomycin C application during uveitic glaucoma surgery is reported." | 1.33 | Early-onset scleral and corneal ectasias following low-dose mitomycin-C-augmented trabeculectomy in a uveitic glaucoma patient. ( Jockin, Y; O'Halloran, H; Pirouzian, A; Scher, C, 2006) |
| "Late bleb leaks may follow months to years after filtering surgery especially with the use of antimetabolites." | 1.31 | [Prognostic outcome of leaking filtering blebs reconstruction with rotational conjunctival flaps]. ( Ayed, T; Hamard, H; Hamard, P; Quesnot, S; Tazartes, M, 2001) |
| "A 71-year-old white woman with primary open angle glaucoma received trabeculectomy with antimetabolite." | 1.29 | Profound long-term hypotony without maculopathy after trabeculectomy with antimetabolite. ( Kaufman, PL; Kee, C, 1994) |
| "Mitomycin is an antibiotic with antineoplastic activity which inhibits fibroblast proliferation in the operative field in glaucoma filtering surgery." | 1.29 | Filtering surgery with mitomycin-C in uncomplicated (primary open angle) glaucoma. ( Doğan, H; Erkiliç, K; Karaküçük, S; Mirza, GE, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 46 (14.38) | 18.2507 |
| 2000's | 91 (28.44) | 29.6817 |
| 2010's | 126 (39.38) | 24.3611 |
| 2020's | 57 (17.81) | 2.80 |
| Authors | Studies |
|---|---|
| Wagner, FM | 2 |
| Schuster, AK | 2 |
| Munder, A | 1 |
| Muehl, M | 1 |
| Chronopoulos, P | 1 |
| Pfeiffer, N | 6 |
| Hoffmann, EM | 3 |
| Kingston, EJ | 1 |
| Zagora, SL | 1 |
| Symes, RJ | 1 |
| Raman, P | 1 |
| McCluskey, PJ | 1 |
| Lusthaus, JA | 1 |
| Liaboe, C | 1 |
| Samuelson, TW | 1 |
| Monja-Alarcón, N | 1 |
| Perucho-Martínez, S | 1 |
| Buenasmañanas-Maeso, M | 1 |
| Toledano-Fernández, N | 1 |
| Romera Romero, P | 1 |
| Duch, S | 1 |
| Moreno-Montañés, J | 2 |
| Botella García, J | 1 |
| Balboa Miró, M | 1 |
| Loscos Arenas, J | 1 |
| Paul, C | 1 |
| Divya, J | 1 |
| Kamal, R | 1 |
| Paul, A | 1 |
| Szigiato, AA | 2 |
| Touma, S | 1 |
| Jabbour, S | 1 |
| Lord, F | 1 |
| Agoumi, Y | 1 |
| Singh, H | 1 |
| Dooling, V | 1 |
| Lappas, A | 1 |
| Dietlein, TS | 3 |
| Ibarz Barberá, M | 2 |
| Martínez-Galdón, F | 1 |
| Caballero-Magro, E | 1 |
| Rodríguez-Piñero, M | 1 |
| Tañá-Rivero, P | 1 |
| Saeed, E | 1 |
| Zalewska, R | 1 |
| Konopińska, J | 1 |
| Senthilkumar, VA | 1 |
| Kumar, MR | 1 |
| Wijesinghe, HK | 2 |
| Uduman, MS | 2 |
| Krishna, SM | 1 |
| Odayappan, A | 1 |
| Puthuran, GV | 2 |
| Winuntamalakul, Y | 1 |
| Chansangpetch, S | 1 |
| Ratanawongphaibul, K | 1 |
| Itthipanichpong, R | 1 |
| Manassakorn, A | 1 |
| Tantisevi, V | 1 |
| Rojanapongpun, P | 1 |
| Kianusch, K | 1 |
| Stingl, J | 1 |
| Seuthe, AM | 1 |
| Erokhina, M | 1 |
| Szurman, P | 1 |
| Haus, A | 1 |
| Lo, WJ | 1 |
| Kuang, TM | 1 |
| Chen, SJ | 1 |
| Hwang, DK | 1 |
| Arish, M | 1 |
| Sargazi, M | 1 |
| Dehghani, S | 1 |
| Sahami, M | 1 |
| Dashipour, A | 1 |
| Sarhadi, S | 1 |
| Rouientan, H | 1 |
| Seresirikachorn, K | 1 |
| Thiamthat, W | 1 |
| Annopawong, K | 1 |
| Wanichwecharungruang, B | 1 |
| Friedman, DS | 1 |
| Vu, DM | 1 |
| Baeg, JY | 1 |
| Choi, HS | 1 |
| Lee, SH | 2 |
| Maheshwari, D | 3 |
| Pillai, MR | 3 |
| Kanduri, S | 3 |
| Nair, IJ | 1 |
| Kader, MA | 1 |
| Ramakrishnan, R | 4 |
| Majtanova, N | 1 |
| Keri, P | 1 |
| Kriskova, P | 1 |
| Kurilova, V | 1 |
| Cholevik, D | 1 |
| Majtan, J | 1 |
| Kolar, P | 1 |
| Lin, MM | 1 |
| Morgan, WH | 1 |
| Kolomeyer, NN | 1 |
| Moster, SJ | 1 |
| Zheng, CX | 1 |
| Giubilato, A | 1 |
| Moster, MR | 5 |
| Pathak Ray, V | 1 |
| Chaironika, N | 1 |
| Gupta, S | 5 |
| Choudhari, NS | 1 |
| Midha, N | 2 |
| Gillmann, K | 2 |
| Chaudhary, A | 2 |
| Mermoud, A | 2 |
| Mansouri, K | 4 |
| Gupta, C | 1 |
| Mathews, D | 1 |
| Pathak-Ray, V | 1 |
| Kadar, MA | 2 |
| Camp, AS | 1 |
| Weinreb, RN | 2 |
| Mano, SS | 1 |
| Esteves, RM | 1 |
| Ferreira, NP | 1 |
| Abegão Pinto, L | 2 |
| Holmes, D | 1 |
| Hui, MMP | 1 |
| Clement, C | 1 |
| Jóhannesson, G | 1 |
| Gottfredsdóttir, MS | 1 |
| Ásgrimsdóttir, GM | 1 |
| Loftsson, T | 1 |
| Stefánsson, E | 1 |
| Allam, RSHM | 1 |
| Raafat, KA | 1 |
| Abdel-Hamid, RM | 1 |
| Bravetti, GE | 1 |
| Rao, HL | 3 |
| Schlenker, MB | 1 |
| Durr, GM | 1 |
| Michaelov, E | 1 |
| Ahmed, IIK | 1 |
| Cutolo, CA | 2 |
| Iester, M | 1 |
| Bagnis, A | 2 |
| Bonzano, C | 2 |
| Negri, L | 1 |
| Olivari, S | 1 |
| Cappelli, F | 1 |
| Testa, V | 1 |
| Sindaco, D | 1 |
| Pizzorno, C | 1 |
| Scotto, R | 2 |
| Saccheggiani, M | 1 |
| Traverso, CE | 3 |
| Barequet, D | 1 |
| Rosenfeld, E | 1 |
| Rabina, G | 1 |
| Shemesh, G | 1 |
| Kurtz, S | 1 |
| Vastardis, I | 1 |
| Fili, S | 1 |
| Perdikakis, G | 1 |
| Gatzioufas, Z | 1 |
| Kohlhaas, M | 1 |
| Kudsieh, B | 1 |
| Casado López de la Franca, E | 1 |
| Díez Gómez, MA | 1 |
| Ruiz Moreno, JM | 1 |
| Sugimoto, K | 1 |
| Asano-Shimizu, K | 1 |
| Murata, H | 2 |
| Yamashita, T | 1 |
| Asaoka, R | 1 |
| Gedde, SJ | 5 |
| Feuer, WJ | 4 |
| Chen, PP | 4 |
| Heuer, DK | 2 |
| Singh, K | 5 |
| Wright, MM | 2 |
| Do, JL | 1 |
| Xu, BY | 1 |
| Wong, B | 1 |
| Camp, A | 1 |
| Ngai, P | 1 |
| Long, C | 1 |
| Proudfoot, J | 1 |
| Moghimi, S | 1 |
| Yan, D | 1 |
| Welsbie, DS | 1 |
| Hamdi, MM | 1 |
| Hamdi, IM | 1 |
| Pillunat, KR | 1 |
| Orphal, J | 1 |
| Haase, M | 1 |
| Pillunat, LE | 1 |
| Herber, R | 1 |
| Gutiérrez-Ortiz, C | 1 |
| Rodrigo-Rey, S | 1 |
| Fontana, L | 1 |
| De Maria, M | 1 |
| Caristia, A | 1 |
| Mastrofilippo, V | 1 |
| Braglia, L | 1 |
| Iannetta, D | 1 |
| Scarale, GP | 1 |
| Batlle, JF | 2 |
| Corona, A | 1 |
| Albuquerque, R | 1 |
| Theilig, T | 1 |
| Rehak, M | 1 |
| Busch, C | 1 |
| Bormann, C | 1 |
| Schargus, M | 1 |
| Unterlauft, JD | 1 |
| Bedar, MS | 1 |
| Kellner, U | 1 |
| Jagannathan, J | 1 |
| George, R | 2 |
| Shantha, B | 1 |
| Vijaya, L | 1 |
| Ho, DCW | 1 |
| Perera, SA | 2 |
| Hla, MH | 1 |
| Ho, CL | 2 |
| Elksne, E | 1 |
| Mercieca, K | 2 |
| Prokosch-Willing, V | 1 |
| Durai, I | 1 |
| Pallamparthy, S | 1 |
| Krishnadas, SR | 1 |
| Robin, AL | 2 |
| Palmberg, P | 2 |
| Michaels, L | 1 |
| Holland, L | 1 |
| Morales Fernández, L | 1 |
| Tañá Rivero, P | 1 |
| Gómez de Liaño, R | 1 |
| Teus, MA | 1 |
| José, P | 1 |
| Teixeira, FJ | 1 |
| Barão, R | 1 |
| Sousa, DC | 1 |
| Marques, RE | 1 |
| Barata, ADO | 1 |
| Marques-Neves, C | 1 |
| Alves, M | 1 |
| Papoila, AL | 1 |
| Stalmans, I | 1 |
| Silva, JP | 1 |
| Denkel, L | 1 |
| Hohberger, B | 1 |
| Lämmer, R | 1 |
| Baker, ND | 1 |
| Barnebey, HS | 2 |
| Stiles, MC | 1 |
| Vold, SD | 1 |
| Khatana, AK | 2 |
| Flowers, BE | 1 |
| Grover, DS | 1 |
| Strouthidis, NG | 1 |
| Panarelli, JF | 3 |
| Dada, T | 2 |
| Sharma, A | 2 |
| Angmo, D | 2 |
| Sihota, R | 2 |
| Vahedian, Z | 2 |
| Fakhraie, G | 2 |
| Faraji, M | 1 |
| Tabatabaei, SM | 1 |
| Kong, YXG | 1 |
| Chung, IY | 2 |
| Ang, GS | 2 |
| Wirbelauer, C | 1 |
| Mertens, CN | 1 |
| Vinod, K | 1 |
| Chang, TC | 1 |
| Parrish, RK | 2 |
| Mafi, M | 1 |
| Zarei, R | 1 |
| Eslami, Y | 1 |
| Ghadimi, H | 1 |
| Mohebbi, M | 1 |
| Romera-Romero, P | 1 |
| Loscos-Arenas, J | 1 |
| Moll-Udina, A | 1 |
| Romanic-Bubalo, N | 1 |
| Castellvi-Manent, J | 1 |
| Valldeperas, X | 2 |
| Almobarak, FA | 2 |
| Alharbi, AH | 2 |
| Morales, J | 2 |
| Aljadaan, I | 2 |
| Yadava, U | 1 |
| Jaisingh, K | 1 |
| Dangda, S | 2 |
| Thacker, P | 1 |
| Goel, Y | 1 |
| Schiffman, JC | 2 |
| Shi, W | 2 |
| Jo, SH | 1 |
| Seo, JH | 1 |
| Garris, WJ | 1 |
| Le, C | 1 |
| Zurakowski, D | 3 |
| Ayyala, RS | 4 |
| Salinas, L | 1 |
| Kim, GN | 1 |
| Shin, MH | 1 |
| Ahn, JY | 1 |
| Han, YS | 1 |
| Seo, SW | 1 |
| Park, JM | 1 |
| Yoo, JM | 1 |
| Kim, SJ | 1 |
| Hoang, TKH | 1 |
| Kim, YK | 1 |
| Jeoung, JW | 1 |
| Park, KH | 1 |
| Shaheer, M | 1 |
| Amjad, A | 1 |
| Ahmed, N | 1 |
| Gizzi, C | 1 |
| Mohamed-Noriega, J | 1 |
| Elkarmouty, A | 1 |
| Scott, A | 1 |
| Ibáñez-Muñoz, A | 1 |
| Soto-Biforcos, VS | 1 |
| Chacón-González, M | 1 |
| Rúa-Galisteo, O | 1 |
| Arrieta-Los Santos, A | 1 |
| Lizuain-Abadía, ME | 1 |
| Del Río Mayor, JL | 1 |
| Bhattacharyya, M | 1 |
| Mutreja, A | 1 |
| Moeller, KL | 1 |
| Smith, M | 2 |
| Charles, R | 1 |
| Abdel-Hay, A | 1 |
| Shah, B | 1 |
| Byles, D | 1 |
| Lim, LA | 1 |
| Rossiter, J | 1 |
| Kuo, CH | 1 |
| Chapman, P | 1 |
| Robertson, S | 1 |
| Paletta Guedes, RA | 1 |
| Gravina, DM | 1 |
| Paletta Guedes, VM | 1 |
| Chaoubah, A | 1 |
| Mostafaei, A | 1 |
| Taheri, N | 1 |
| Ghojazadeh, M | 1 |
| Latifi, A | 1 |
| Moghaddam, N | 1 |
| Kozobolis, V | 1 |
| Kalogianni, E | 1 |
| Sideroudi, H | 1 |
| Laspas, P | 1 |
| Leichsenring, V | 1 |
| Hoffmann, E | 1 |
| Preussner, R | 1 |
| Wahl, J | 2 |
| Del Noce, C | 1 |
| Vagge, A | 1 |
| Wadke, V | 1 |
| Lingam, V | 1 |
| George, AE | 1 |
| Ganesh, SK | 1 |
| Biswas, J | 1 |
| Balekudaru, S | 1 |
| Sorkhabi, R | 1 |
| Najafzadeh, F | 1 |
| Sadeghi, A | 1 |
| Ahoor, M | 1 |
| Mahdavifard, A | 1 |
| Bayraktar, S | 1 |
| Oray, M | 1 |
| Altan, C | 1 |
| Basarir, B | 1 |
| Izgi, B | 1 |
| Tugal-Tutkun, I | 1 |
| Gupta, V | 3 |
| Shaikh, NF | 1 |
| Rong, SS | 1 |
| Meng, HL | 1 |
| Fan, SJ | 1 |
| Wang, NL | 1 |
| Liang, YB | 1 |
| Huang, Y | 1 |
| Wang, R | 1 |
| He, Y | 1 |
| Chang, X | 1 |
| Cui, HY | 1 |
| Zhang, ZH | 1 |
| Li, SZ | 1 |
| Liu, LR | 1 |
| Thomas, R | 1 |
| Okimoto, S | 1 |
| Kiuchi, Y | 2 |
| Akita, T | 1 |
| Tanaka, J | 1 |
| You, YA | 1 |
| Wu, Y | 1 |
| Hu, S | 1 |
| Besley, J | 1 |
| Lee, GA | 1 |
| Whitehead, K | 1 |
| Shah, P | 1 |
| Senthil, S | 2 |
| Babu, JG | 1 |
| Mandal, AK | 1 |
| Garudadri, CS | 2 |
| Ogata-Iwao, M | 4 |
| Inatani, M | 6 |
| Takihara, Y | 5 |
| Inoue, T | 4 |
| Iwao, K | 5 |
| Tanihara, H | 6 |
| Brüggemann, A | 1 |
| Despouy, JT | 1 |
| Wegent, A | 1 |
| Müller, M | 1 |
| Akkan, JU | 1 |
| Cilsim, S | 1 |
| Rulli, E | 1 |
| Biagioli, E | 1 |
| Riva, I | 1 |
| Gambirasio, G | 1 |
| De Simone, I | 1 |
| Floriani, I | 1 |
| Quaranta, L | 2 |
| Dean, WH | 1 |
| Turner, SA | 1 |
| McNaught, AI | 1 |
| Kawai, M | 1 |
| Schoenberg, ED | 1 |
| Chaudhry, AL | 2 |
| Chod, R | 1 |
| Rosentreter, A | 2 |
| Gaki, S | 1 |
| Cursiefen, C | 1 |
| Wadhwani, M | 1 |
| Sehgal, V | 1 |
| Sharma, S | 1 |
| Darian-Smith, E | 1 |
| Toh, T | 1 |
| Muniesa, MJ | 1 |
| González, S | 1 |
| Buetas, P | 1 |
| López, S | 1 |
| Sánchez, C | 1 |
| Matias-Guiu, X | 1 |
| Khairy, HA | 2 |
| Elsawy, MF | 2 |
| Pro, MJ | 1 |
| Freidl, KB | 1 |
| Neylan, CJ | 1 |
| Sawchyn, AK | 1 |
| Wizov, SS | 1 |
| Khandelwal, RR | 1 |
| Raje, D | 1 |
| Rathi, A | 1 |
| Agashe, A | 1 |
| Majumdar, M | 1 |
| Khandelwal, R | 1 |
| Foulsham, WS | 1 |
| Fu, L | 1 |
| Tatham, AJ | 1 |
| Loscos, J | 1 |
| Langohr, K | 1 |
| Langhor, K | 1 |
| Parera, À | 1 |
| Romera, P | 1 |
| Sabala, A | 1 |
| de la Cámara, J | 1 |
| Aoyama, Y | 1 |
| Aihara, M | 2 |
| Voykov, B | 1 |
| Rohrbach, JM | 1 |
| Kaplan, RI | 1 |
| De Moraes, CG | 1 |
| Cioffi, GA | 1 |
| Al-Aswad, LA | 1 |
| Blumberg, DM | 1 |
| Chen, DZ | 1 |
| Koh, V | 2 |
| Sng, C | 2 |
| Aquino, MC | 1 |
| Chew, P | 2 |
| Li, B | 1 |
| Zhang, M | 1 |
| Liu, W | 1 |
| Wang, J | 2 |
| Chandra, A | 1 |
| Pandey, RM | 1 |
| Chihara, E | 4 |
| Hayashi, K | 3 |
| Na, JH | 1 |
| Sung, KR | 1 |
| Shin, JA | 1 |
| Moon, JI | 1 |
| Cherof, AM | 1 |
| SooHoo, JR | 1 |
| Kahook, MY | 2 |
| Seibold, LK | 1 |
| Allan, EJ | 1 |
| Jones, JM | 1 |
| Ding, K | 1 |
| Khaimi, MA | 1 |
| Bettin, P | 1 |
| Di Matteo, F | 1 |
| Rabiolo, A | 1 |
| Fiori, M | 1 |
| Ciampi, C | 1 |
| Bandello, F | 1 |
| Kwong, TQ | 1 |
| Mahroo, O | 1 |
| Scoppettuolo, E | 1 |
| Ansari, E | 1 |
| Leinonen, S | 1 |
| Kotaniemi, K | 1 |
| Kivelä, T | 1 |
| Majander, A | 1 |
| Lim, SH | 1 |
| Cha, SC | 2 |
| Banitt, MR | 1 |
| Fantes, F | 1 |
| Riss, I | 1 |
| Pinchuk, L | 1 |
| Alburquerque, R | 1 |
| Kato, YP | 1 |
| Arrieta, E | 1 |
| Peralta, AC | 1 |
| Weber, BA | 1 |
| Parel, JM | 1 |
| Figueiredo, ARM | 1 |
| Sampaio, IC | 1 |
| Menéres, MJFDS | 1 |
| Spaeth, GL | 1 |
| Cillino, S | 2 |
| Casuccio, A | 2 |
| Di Pace, F | 2 |
| Cagini, C | 1 |
| Ferraro, LL | 1 |
| Cillino, G | 2 |
| Pérez-Torregrosa, VT | 1 |
| Olate-Pérez, Á | 1 |
| Cerdà-Ibáñez, M | 1 |
| Gargallo-Benedicto, A | 1 |
| Osorio-Alayo, V | 1 |
| Barreiro-Rego, A | 1 |
| Duch-Samper, A | 1 |
| Wang, BZ | 1 |
| Meagher, P | 1 |
| Kashiwagi, K | 1 |
| Kogure, S | 1 |
| Mabuchi, F | 1 |
| Chiba, T | 1 |
| Yamamoto, T | 6 |
| Kuwayama, Y | 1 |
| Araie, M | 7 |
| El-Saied, HM | 1 |
| Abdelhakim, MA | 1 |
| Kaushik, J | 1 |
| Parihar, JK | 1 |
| Jain, VK | 1 |
| Nath, P | 1 |
| Durgapal, P | 1 |
| Ram, J | 1 |
| Hirunpatravong, P | 1 |
| Reza, A | 1 |
| Romero, P | 1 |
| Kim, EA | 1 |
| Nouri-Mahdavi, K | 4 |
| Law, SK | 3 |
| Morales, E | 1 |
| Caprioli, J | 6 |
| Tanaka, D | 1 |
| Nakanishi, H | 1 |
| Hangai, M | 1 |
| Akagi, T | 1 |
| Morooka, S | 1 |
| Ikeda, HO | 1 |
| Yoshimura, N | 2 |
| Said-Ahmed, K | 1 |
| Schlenker, M | 1 |
| Ahmed, II | 2 |
| Pakravan, M | 1 |
| Esfandiari, H | 1 |
| Yazdani, S | 1 |
| Douzandeh, A | 1 |
| Amouhashemi, N | 1 |
| Yaseri, M | 1 |
| Pakravan, P | 1 |
| Nakakura, S | 1 |
| Noguchi, A | 1 |
| Tabuchi, H | 1 |
| Chen, D | 1 |
| Aquino, CM | 1 |
| Aduan, J | 1 |
| Chee, LS | 1 |
| El-Sayyad, F | 1 |
| El-Saied, HMA | 1 |
| Abdelhakim, MASE | 1 |
| Reibaldi, A | 2 |
| Uva, MG | 2 |
| Longo, A | 1 |
| Mavrikakis, E | 1 |
| Buys, YM | 1 |
| Lloyd, M | 1 |
| Giegengack, M | 1 |
| Morrison, JC | 1 |
| Storr-Paulsen, T | 1 |
| Norregaard, JC | 2 |
| Ahmed, S | 1 |
| Storr-Paulsen, A | 2 |
| Cheng, JW | 3 |
| Xi, GL | 2 |
| Wei, RL | 3 |
| Cai, JP | 3 |
| Li, Y | 5 |
| Jurowska-Liput, J | 1 |
| Krzyzanowska, P | 1 |
| Szelepin, Ł | 1 |
| Nizankowska, MH | 1 |
| Okazaki, K | 1 |
| Takahashi, H | 1 |
| Shoji, T | 1 |
| Adachi, H | 1 |
| Ollikainen, M | 1 |
| Puustjärvi, T | 1 |
| Rekonen, P | 1 |
| Uusitalo, H | 1 |
| Teräsvirta, M | 1 |
| Ravinet, E | 1 |
| Kaburaki, T | 1 |
| Koshino, T | 1 |
| Kawashima, H | 1 |
| Numaga, J | 1 |
| Tomidokoro, A | 3 |
| Shirato, S | 6 |
| Ciancaglini, M | 3 |
| Carpineto, P | 3 |
| Agnifili, L | 1 |
| Nubile, M | 1 |
| Fasanella, V | 1 |
| Mattei, PA | 1 |
| Mastropasqua, L | 3 |
| Ollikainen, ML | 1 |
| Puustjärvi, TJ | 1 |
| Rekonen, PK | 1 |
| Uusitalo, HM | 1 |
| Teräsvirta, ME | 1 |
| Saldana, M | 1 |
| Gupta, D | 1 |
| Khandwala, M | 1 |
| Beigi, B | 1 |
| Pérez-López, M | 1 |
| Nozal, CC | 1 |
| López, MM | 1 |
| García-Pérez, JL | 1 |
| Negrete, FM | 1 |
| Maheshwari, R | 1 |
| Prasad, KK | 1 |
| Schwartz, AL | 1 |
| Albano, M | 1 |
| Anand, N | 2 |
| Kumar, A | 1 |
| Gupta, A | 1 |
| Hoehn, R | 1 |
| Lamparter, J | 1 |
| Vossmerbaeumer, U | 1 |
| Mavrakanas, N | 1 |
| Mendrinos, E | 1 |
| Shaarawy, T | 1 |
| Chiseliţă, D | 1 |
| Cantemir, A | 1 |
| Ilieş, I | 1 |
| Klink, T | 1 |
| Kann, G | 1 |
| Ellinger, P | 1 |
| Klink, J | 1 |
| Grehn, F | 1 |
| Guthoff, R | 1 |
| Coote, MA | 1 |
| Vasudevan, S | 1 |
| Crowston, JG | 1 |
| Schild, AM | 1 |
| Jordan, JF | 1 |
| Krieglstein, GK | 2 |
| Suh, YW | 1 |
| Yoo, C | 1 |
| Park, JH | 1 |
| Jung, JH | 1 |
| Kim, YY | 5 |
| Geffen, N | 1 |
| Ton, Y | 1 |
| Degani, J | 1 |
| Assia, EI | 1 |
| Seto, T | 2 |
| Iwao, M | 1 |
| Kasaoka, N | 1 |
| Murakami, A | 1 |
| Futa, R | 1 |
| Mathalone, N | 1 |
| Marmor, S | 1 |
| Rahat, MA | 1 |
| Lahat, N | 1 |
| Oron, Y | 2 |
| Geyer, O | 2 |
| Tan, YL | 1 |
| Tsou, PF | 1 |
| Tan, GS | 1 |
| Wong, TT | 1 |
| Aung, T | 2 |
| Fujishiro, T | 1 |
| Mayama, C | 1 |
| Sengupta, S | 1 |
| Venkatesh, R | 1 |
| Ravindran, RD | 1 |
| Mathew, R | 1 |
| Barton, K | 1 |
| Bach-Holm, D | 1 |
| Cheng, SW | 1 |
| Fukuoka, S | 1 |
| Amano, S | 1 |
| Honda, N | 1 |
| Mimura, T | 1 |
| Usui, T | 1 |
| Wei, H | 1 |
| Razeghinejad, MR | 1 |
| Rao, A | 1 |
| Okogbaa, CB | 1 |
| Ghoneim, EM | 1 |
| Abd El Hameed, M | 1 |
| Nilforushan, N | 1 |
| Yadgari, M | 1 |
| Kish, SK | 1 |
| Nassiri, N | 2 |
| Jea, SY | 1 |
| Francis, BA | 2 |
| Vakili, G | 1 |
| Filippopoulos, T | 1 |
| Rhee, DJ | 1 |
| Kapoor, KG | 1 |
| Syed, MF | 1 |
| Awai-Kasaoka, N | 1 |
| Kawaguchi, A | 1 |
| Sawada, A | 3 |
| Shoaib, KK | 1 |
| Okinami, S | 2 |
| Hogewind, BF | 1 |
| Pijl, B | 1 |
| Hoyng, CB | 1 |
| Theelen, T | 2 |
| Al-Obeidan, SA | 1 |
| Osman, Eel-D | 1 |
| Dewedar, AS | 1 |
| Kestelyn, P | 1 |
| Mousa, A | 1 |
| Zahid, S | 1 |
| Musch, DC | 1 |
| Niziol, LM | 1 |
| Lichter, PR | 1 |
| Hosseini, H | 1 |
| Saidi, E | 1 |
| Neelakanta, G | 1 |
| Giaconi, JA | 1 |
| Kozobolis, VP | 2 |
| Christodoulakis, EV | 2 |
| Tzanakis, N | 1 |
| Zacharopoulos, I | 1 |
| Pallikaris, IG | 2 |
| Shin, DH | 12 |
| Iskander, NG | 1 |
| Ahee, JA | 1 |
| Singal, IP | 1 |
| Kim, C | 9 |
| Hughes, BA | 7 |
| Eliassi-Rad, B | 1 |
| Siganos, CS | 1 |
| Lazarov, NP | 1 |
| Koutentaki, MG | 1 |
| Jonas, JB | 1 |
| Dugrillon, A | 1 |
| Klüter, H | 1 |
| Kamppeter, B | 1 |
| Hu, CY | 1 |
| Matsuo, H | 1 |
| Tomita, G | 1 |
| Suzuki, Y | 1 |
| Tanaka, S | 1 |
| Yang, S | 1 |
| Ma, X | 1 |
| Iwach, AG | 1 |
| Delgado, MF | 1 |
| Novack, GD | 1 |
| Nguyen, N | 1 |
| Wong, PC | 1 |
| Kobayashi, H | 2 |
| Kobayashi, K | 2 |
| Aydin, A | 1 |
| Wollstein, G | 1 |
| Price, LL | 1 |
| Fujimoto, JG | 1 |
| Schuman, JS | 1 |
| Sacu, S | 1 |
| Rainer, G | 1 |
| Findl, O | 1 |
| Georgopoulos, M | 1 |
| Vass, C | 1 |
| Zalish, M | 2 |
| Westfall, AC | 1 |
| Ng, JD | 1 |
| Samples, JR | 1 |
| Weissman, JL | 1 |
| Kawashima, M | 1 |
| Yamazaki, Y | 1 |
| Mizuki, K | 1 |
| Hayamizu, F | 1 |
| Nakagami, T | 1 |
| Tanaka, C | 1 |
| Awwad, ST | 1 |
| Ma'luf, RN | 1 |
| Noureddin, B | 1 |
| Das, J | 1 |
| Sharma, P | 1 |
| Chaudhuri, Z | 1 |
| Mandić, Z | 1 |
| Bencić, G | 1 |
| Zorić Geber, M | 1 |
| Bojić, L | 1 |
| O'Brart, DP | 2 |
| Shiew, M | 1 |
| Edmunds, B | 1 |
| Schwenn, O | 1 |
| Springer, C | 1 |
| Troost, A | 1 |
| Yun, SH | 1 |
| Gierek-Lapińska, A | 1 |
| Leszczyński, R | 1 |
| Wróbel, A | 1 |
| Ye, W | 1 |
| Sun, J | 1 |
| Zhong, Y | 1 |
| Landa, G | 1 |
| Pollack, A | 1 |
| Rachmiel, R | 1 |
| Bukelman, A | 1 |
| Marcovich, A | 1 |
| Savini, G | 1 |
| Zanini, M | 1 |
| Barboni, P | 1 |
| Topouzis, F | 1 |
| Tranos, P | 1 |
| Koskosas, A | 1 |
| Pappas, T | 1 |
| Anastasopoulos, E | 1 |
| Dimitrakos, S | 1 |
| Wilson, MR | 2 |
| Moster, ML | 1 |
| Tello, CA | 1 |
| Khaw, PT | 1 |
| Rebolleda, G | 1 |
| Muñoz-Negrete, FJ | 1 |
| Ralli, M | 2 |
| Mielke, C | 1 |
| Dawda, VK | 1 |
| Fontana, H | 2 |
| Banitt, M | 1 |
| Juzych, MS | 7 |
| Chopra, V | 1 |
| Miyake, T | 1 |
| Miyake, K | 1 |
| Sugiyama, K | 1 |
| Kitazawa, Y | 4 |
| Lumba, J | 1 |
| Hesse, RJ | 1 |
| Shigeeda, T | 1 |
| Chen, YN | 1 |
| Kessing, SV | 1 |
| Heegaard, S | 1 |
| Nissen, OI | 1 |
| Schallenberg, M | 1 |
| Steuhl, KP | 1 |
| Selbach, JM | 1 |
| Drolsum, L | 1 |
| Willoch, C | 1 |
| Nicolaissen, B | 1 |
| Pirouzian, A | 1 |
| O'Halloran, H | 1 |
| Scher, C | 1 |
| Jockin, Y | 1 |
| Wesseling, P | 1 |
| Keunen, JE | 1 |
| Klevering, BJ | 1 |
| Palop, JA | 1 |
| García-Gómez, P | 1 |
| Heras, H | 1 |
| Cristóbal, JA | 1 |
| Yalvac, IS | 1 |
| Satana, B | 1 |
| Ozkan, G | 1 |
| Eksioglu, U | 1 |
| Duman, S | 1 |
| Labbé, A | 2 |
| Hamard, P | 3 |
| Iordanidou, V | 1 |
| Dupont-Monod, S | 1 |
| Baudouin, C | 2 |
| Aykan, U | 1 |
| Bilge, AH | 1 |
| Akin, T | 1 |
| Certel, I | 1 |
| Bayer, A | 1 |
| Jones, LD | 1 |
| Ramanathan, S | 1 |
| Sandramouli, S | 1 |
| Nguyen, AM | 1 |
| Coleman, AL | 1 |
| Cotran, PR | 1 |
| Roh, S | 1 |
| McGwin, G | 1 |
| Li, G | 1 |
| O'Hearn, T | 1 |
| Yiu, S | 1 |
| Arevalo, JF | 1 |
| Mendoza, AJ | 1 |
| Millan, FA | 1 |
| Fuenmayor-Rivera, D | 1 |
| Hueber, A | 1 |
| Esser, JM | 1 |
| Kociok, N | 1 |
| Welsandt, G | 1 |
| Lüke, C | 1 |
| Roters, S | 1 |
| Esser, PJ | 1 |
| Amar, N | 1 |
| Dupas, B | 1 |
| Lodato, G | 1 |
| Danesh-Meyer, HV | 1 |
| Papchenko, T | 1 |
| Tan, YW | 1 |
| Gamble, GD | 1 |
| El-Saheb, H | 1 |
| Lesk, MR | 1 |
| Eha, J | 1 |
| Schmidt-Erfurth, U | 2 |
| Wetzel, W | 2 |
| Dröge, G | 2 |
| Häring, G | 1 |
| Behrendt, S | 1 |
| Birngruber, R | 2 |
| Kupin, TH | 2 |
| Olivier, MM | 1 |
| Lamping, KA | 1 |
| Belkin, JK | 1 |
| Oh, SY | 1 |
| Youn, DH | 1 |
| Kim, DM | 1 |
| Hong, C | 1 |
| Kee, C | 1 |
| Kaufman, PL | 1 |
| Mirza, GE | 1 |
| Karaküçük, S | 1 |
| Doğan, H | 1 |
| Erkiliç, K | 1 |
| Suemori-Matsushita, H | 1 |
| Kawase, K | 1 |
| Singh, G | 1 |
| Kaur, J | 1 |
| Dogra, A | 1 |
| Nishida, A | 1 |
| Kodo, M | 1 |
| Matsumura, M | 1 |
| Yamamoto, M | 1 |
| Tsukada, T | 1 |
| Costa, VP | 2 |
| Wilson, RP | 1 |
| Schmidt, CM | 1 |
| Gandham, S | 1 |
| Hara, T | 3 |
| Miyata, N | 1 |
| Eguchi, K | 1 |
| Takada, M | 1 |
| Smith, MF | 1 |
| Doyle, JW | 1 |
| Tressler, CS | 1 |
| Cyrlin, MN | 1 |
| Rosenshein, JS | 1 |
| Fazio, R | 1 |
| Dev, S | 1 |
| Herndon, L | 1 |
| Shields, MB | 1 |
| Susanna, R | 3 |
| Takahashi, W | 1 |
| Nicolela, M | 1 |
| Ruderman, JM | 1 |
| Fundingsland, B | 1 |
| Meyer, MA | 1 |
| Song, MS | 4 |
| Yang, KJ | 3 |
| Shah, MI | 1 |
| Obertynski, T | 1 |
| Masuda, K | 1 |
| Lu, DW | 1 |
| Azuara-Blanco, A | 1 |
| Katz, LJ | 1 |
| Simone, PA | 1 |
| Reed, SY | 2 |
| Krishnadas, R | 1 |
| Smith, SD | 2 |
| Katz, JD | 1 |
| Selvaraj, S | 1 |
| Skuta, GL | 1 |
| Bhatnagar, R | 1 |
| Kim, JW | 1 |
| Lemon, LC | 3 |
| Lee, JH | 1 |
| Bendel, RE | 2 |
| Urban, RC | 1 |
| Krishnamurthy, MS | 1 |
| Mendelblatt, DJ | 1 |
| Ren, J | 4 |
| Glover, KB | 2 |
| Sheth, N | 1 |
| Shah, M | 1 |
| Byrd, S | 1 |
| Egbert, PR | 1 |
| Budenz, D | 1 |
| Gallenga, PE | 2 |
| Zuppardi, E | 2 |
| Yamamoto, S | 1 |
| Weatherwax, AL | 1 |
| Pearlman, RB | 1 |
| Muenk, SB | 1 |
| Daugeliene, L | 1 |
| Kent, AR | 1 |
| Dubiner, HB | 1 |
| Whitaker, R | 1 |
| Mundorf, TK | 1 |
| Stewart, JA | 1 |
| Cate, EA | 1 |
| Stewart, WC | 1 |
| Weene, LE | 1 |
| Lobefalo, L | 1 |
| Sexton, RM | 1 |
| Ginde, SA | 1 |
| Lee, D | 1 |
| Xia, X | 2 |
| Huang, P | 2 |
| Jiang, Y | 1 |
| Wang, C | 1 |
| Yang, C | 1 |
| Suzuki, R | 1 |
| Nakayama, M | 1 |
| Satoh, N | 1 |
| Freedman, SF | 1 |
| McCormick, K | 1 |
| Cox, TA | 1 |
| Hitchings, RA | 3 |
| Quaranta, CA | 1 |
| Liu, S | 1 |
| Kapetansky, FM | 1 |
| Kapetansky, SD | 1 |
| Hagiwara, Y | 1 |
| Membrey, WL | 2 |
| Poinoosawmy, DP | 2 |
| Bunce, C | 2 |
| Ober, MD | 1 |
| Nootheti, P | 1 |
| Kim, PH | 2 |
| Mendis, U | 1 |
| Paliwal, A | 1 |
| Alsagoff, Z | 1 |
| Chew, PT | 1 |
| Chee, CK | 1 |
| Wong, JS | 1 |
| Kook, MS | 1 |
| Kim, HB | 1 |
| Lee, SU | 1 |
| Melamed, S | 1 |
| Traverso, C | 1 |
| Fitzke, FW | 1 |
| Malta, RF | 1 |
| Barboza, WL | 1 |
| Vasconcellos, JP | 1 |
| Tazartes, M | 1 |
| Ayed, T | 1 |
| Quesnot, S | 1 |
| Hamard, H | 1 |
| Okada, K | 1 |
| Tsukamoto, H | 1 |
| Masumoto, M | 1 |
| Jian, K | 1 |
| Okada, M | 1 |
| Mochizuki, H | 1 |
| Mishima, HK | 1 |
| Stamper, R | 1 |
| Casson, RJ | 1 |
| Salmon, JF | 1 |
| Tsai, JC | 1 |
| Sivak-Callcott, JA | 1 |
| Haik, BG | 1 |
| Zhang, J | 1 |
| McLean, IW | 1 |
| Wu, J | 1 |
| Vandenbelt, SM | 1 |
| Gross, JP | 1 |
| Keole, NS | 1 |
| Birt, CM | 1 |
| Zhang, X | 1 |
| Peng, D | 1 |
| Zhou, W | 1 |
| Ye, T | 1 |
| Ge, J | 1 |
| Fukuchi, T | 1 |
| Hayakawa, Y | 1 |
| Hara, H | 1 |
| Abe, H | 1 |
| Vergés, C | 1 |
| Llevat, E | 1 |
| Bardavio, J | 1 |
| Rowlands, E | 1 |
| Islam, N | 1 |
| Noury, AM | 1 |
| Bindlish, R | 1 |
| Condon, GP | 1 |
| Schlosser, JD | 1 |
| D'Antonio, J | 1 |
| Lauer, KB | 1 |
| Lehrer, R | 1 |
| Mietz, H | 1 |
| Jacobi, PC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Macular Thickness in Patients With Glaucoma in Use of Topical Prostaglandin Analogue Undergoing Trabeculectomy With Mitomycin C[NCT06000280] | 37 participants (Actual) | Interventional | 2021-01-04 | Completed | |||
| Primary Tube Versus Trabeculectomy Study[NCT00666237] | Phase 4 | 242 participants (Actual) | Interventional | 2008-04-01 | Completed | ||
| Clinical Study of the Safety and Performance of the Miami InnFocus Drainage Implant to Relieve Glaucoma Symptoms[NCT00772330] | 23 participants (Actual) | Interventional | 2007-10-31 | Completed | |||
| Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)[NCT00494923] | 2,500 participants (Anticipated) | Observational | 1999-01-31 | Recruiting | |||
| Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation - a Prospective Cohort Study at the Ophthalmology Department Klinikum Klagenfurt[NCT06174324] | 100 participants (Anticipated) | Observational | 2021-10-12 | Recruiting | |||
| A Randomized Study Comparing the Safety and Efficacy of the InnFocus MicroShunt® Glaucoma Drainage System to Standard Trabeculectomy In Subjects With Primary Open Angle Glaucoma[NCT01881425] | 732 participants (Actual) | Interventional | 2015-12-15 | Completed | |||
| Deep Sclerectomy vs Xen in Solo Procedure: Comparative Study, Efficacy and Safety Profile[NCT05201378] | 282 participants (Actual) | Observational | 2021-07-15 | Completed | |||
| Lucentis Versus Mitomycin C as Adjunctive Agent During Trabeculectomy Surgery[NCT00626782] | Phase 2/Phase 3 | 24 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Phaco-UCP; Combined Phacoemulsification and Ultrasound Ciliary Plasty Versus Phacoemulsification Alone for Management of Coexisting Cataract and Open Angle Glaucoma[NCT04430647] | 61 participants (Actual) | Interventional | 2018-03-01 | Completed | |||
| Comparison of Effectiveness and Safety of Eye Fixation Types During Combined Glaucoma Procedures[NCT03797846] | 41 participants (Actual) | Interventional | 2018-01-01 | Completed | |||
| Comparison of Surgical Treatment Options for Primary Congenital and Developmental Glaucomas[NCT04647929] | 0 participants (Actual) | Interventional | 2020-12-01 | Withdrawn (stopped due to Funding for the study could not be found.) | |||
| XEN45 Gel Stent Implantation in Glaucoma Surgery[NCT03138928] | 15 participants (Actual) | Observational | 2015-01-31 | Completed | |||
| Bleb Function and Morphology With Intratendon Injection of 0.1 mg MMC in Comparison With Conventional Subtenon Application of 0.02% MMC Soaked Sponges in Trabeculectomy[NCT02385370] | Phase 3 | 126 participants (Anticipated) | Interventional | 2014-12-31 | Recruiting | ||
| Occlusion Prevention for Trabeculectomy Procedures Using Combination Ranibizumab and Mitomycin C (MMC) During Surgery (OCTOPUS Study)[NCT00661583] | Phase 1/Phase 2 | 30 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| [NCT02665884] | 40 participants (Anticipated) | Observational | 2016-02-29 | Not yet recruiting | |||
| Anterior Segment Optical Coherence Tomography Findings in Patients With Ahmed Glaucoma Drainage Implants With Either a Pericardial Patch Graft and Fibrin Tissue Glue or a Partial-Thickness Scleral Flap and Conventional Sutures[NCT00453024] | Phase 2 | 40 participants (Anticipated) | Interventional | 2007-02-28 | Recruiting | ||
| Multidrug Resistance After Trabeculectomy With Mitomycin C[NCT00449631] | 30 participants | Observational | Completed | ||||
| Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy[NCT00695747] | 95 participants (Actual) | Interventional | 1998-01-31 | Completed | |||
| IOP Reduction and Complications of Polymethyl Methacrylate Glaucoma Drainage Device on Glaucoma Patient[NCT04052165] | 150 participants (Actual) | Interventional | 2015-07-01 | Completed | |||
| Re-Trabeculectomy Versus Ahmed Glaucoma Valve Implantation in Secondary Surgical Management of Patients With Refractory Primary Open Angle Glaucoma: a Three-year Comparative Study[NCT01633775] | 100 participants (Actual) | Observational | 2007-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The number of participants requiring reoperation for glaucoma will be reported (NCT00666237)
Timeframe: Up to 5 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Tube Shunt Surgery Group | 21 |
| Trabeculectomy With Mitomycin C | 12 |
Intraocular pressure will be reported in mmHg and measured using Goldmann applanation tonometry or a Tono-Pen. (NCT00666237)
Timeframe: At baseline, At 1 year, At 18 months, At 2 years, At 3 years, At 4 years, At 5 years
| Intervention | mmHg (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Intraocular Pressure: Baseline | Intraocular Pressure: 1 year | Intraocular Pressure: 18 months | Intraocular Pressure: 2 years | Intraocular Pressure: 3 years | Intraocular Pressure: 4 years | Intraocular Pressure: 5 years | |
| Trabeculectomy With Mitomycin C | 23.9 | 12.4 | 12.8 | 12.9 | 12.1 | 13.5 | 13.0 |
| Tube Shunt Surgery Group | 23.3 | 13.8 | 13.5 | 13.6 | 13.9 | 13.5 | 13.4 |
The need for supplemental glaucoma medications will be reported as the number of glaucoma medications used (NCT00666237)
Timeframe: At Baseline, At 1 year, At 18 months, At 2 years, At 3 years, At 4 years, At 5 years
| Intervention | glaucoma medications used (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | 1 year | 18 months | 2 years | 3 years | 4 years | 5 years | |
| Trabeculectomy With Mitomycin C | 3.2 | 0.9 | 0.8 | 1.0 | 1.2 | 1.3 | 1.3 |
| Tube Shunt Surgery Group | 3.1 | 2.1 | 2.1 | 2.2 | 2.1 | 2.3 | 2.2 |
Number of participants with early and late postoperative complications will be reported as per treating physician assessment (NCT00666237)
Timeframe: Up to 5 years
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Early Postoperative Complications | Late Postoperative Complications | |
| Trabeculectomy With Mitomycin C | 40 | 32 |
| Tube Shunt Surgery Group | 24 | 27 |
"Surgical failure is defined as:~Inadequate Intraocular Pressure (IOP) Reduction (IOP > 21 mmHg or reduced < 20% below baseline on 2 consecutive follow-up visits after 3 months)~Reoperation for glaucoma~Persistent hypotony (IOP ≤ 5 mmHg on 2 consecutive visits after 3 months)~Loss of light perception vision" (NCT00666237)
Timeframe: Up to 5 years
| Intervention | Participants (Count of Participants) | |||
|---|---|---|---|---|
| Inadequate IOP reduction | Reoperation for Glaucoma | Loss of light perception vision | Persistent Hypotony | |
| Trabeculectomy With Mitomycin C | 23 | 9 | 1 | 5 |
| Tube Shunt Surgery Group | 31 | 18 | 0 | 0 |
Visual acuity will be reported as the number of correctly identified letters on the Early Treatment Diabetic Retinopathy Study (EDTRS) chart. Total score ranges from 0-100 with the higher score indicating better visual acuity. (NCT00666237)
Timeframe: At baseline, At 5 years
| Intervention | letters (Mean) | |
|---|---|---|
| Baseline | 5 years | |
| Trabeculectomy With Mitomycin C | 73 | 66 |
| Tube Shunt Surgery Group | 73 | 69 |
Visual acuity will be measured using a Snellen chart on logMAR (Logarithm of Minimal Angle of Resolution) scale. Letter-by letter results calculated the visual performance score for each chart read. logMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR visual performance score of 0.0 is equivalent to Snellen visual acuity of 20/20. (NCT00666237)
Timeframe: At Baseline, At 5 years
| Intervention | logMAR (Mean) | |
|---|---|---|
| Baseline | 5 years | |
| Trabeculectomy With Mitomycin C | 0.25 | 0.42 |
| Tube Shunt Surgery Group | 0.20 | 0.30 |
Cases requiring glaucoma re-operation (NCT00772330)
Timeframe: 60 Months
| Intervention | participants (Number) |
|---|---|
| MIDI Arrow | 2 |
The mean surgical procedure time from the time the incision was made in the conjunctiva to the time peritomy closure (NCT00772330)
Timeframe: Day 1
| Intervention | Minutes (Mean) |
|---|---|
| MIDI Arrow | 25.3 |
The number of glaucoma supplemental medications required after the MicroShunt procedure. (NCT00772330)
Timeframe: Day 1 thru Month 3, Month 6, Month 9, Month 12, Month 24, Month 36, Month 48 and Month 60
| Intervention | Medications (Median) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | Day 1 thru Month 3 | Month 6 | Month 9 | Month 12 | Month 24 | Month 36 | Month 48 | Month 60 | |
| The Number of Glaucoma Supplemental Medication | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Maintenance of pressure control throughout the follow-up period, as measured by IOP at each post-operative visit (NCT00772330)
Timeframe: Day 1, Day 7, Week 3, Week 6, Month 3, Month 9, Month 12, Month 24, Month 36, Month 48 and Month 60
| Intervention | mmHg (Mean) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline IOP | Day 1 | Day 7 | Week 3 | Week 6 | Month 3 | Month 6 | Month 9 | Month 12 | Month 24 | Month 36 | Month 48 | Month 60 | |
| To Assess Safety and Performance of the MIDI Arrow in Patients w Glaucoma | 23.78 | 9.6 | 7.8 | 7.4 | 8.9 | 10.8 | 12 | 11.2 | 11.3 | 12 | 11.8 | 12 | 11.5 |
Success: IOP < 15 mmHg or IOP reduced from baseline (pre-operative level) by ≥ 20% (without glaucoma reoperation, such as a trabeculectomy to improve aqueous drainage or implantation of another drainage implant). (NCT00772330)
Timeframe: Day 1, Day 7, Week 3, Week 6, Month 3, Month 9, Month 12, Month 24, Month 36, Month 48 and Month 60
| Intervention | Participants (Count of Participants) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Day 1 | Day 7 | Week 3 | Week 6 | Month 3 | Month 9 | Month 12 | Month 24 | Month 36 | Month 48 | Month 60 | |
| To Assess Safety and Performance of the MIDI Arrow in Patients w Glaucoma | 22 | 23 | 23 | 23 | 22 | 23 | 22 | 21 | 20 | 17 | 18 |
Defined by ease of insertion of the device into the anterior chamber, based on an Investigator evaluation rating (5-point scale, with 1 being difficult and 5 being easy); (NCT00772330)
Timeframe: Day 1
| Intervention | Participants (Number) | ||||
|---|---|---|---|---|---|
| 1 - Difficult | 2 | 3 | 4 | 5 - Easy | |
| MIDI Arrow | 0 | 0 | 0 | 6 | 17 |
Visual acuity measured at each post-operative visit from baseline. (NCT00772330)
Timeframe: Day 1, Day 7, Week 3, Week 6, Month 3, Month 9, Month 12, Month 24, Month 36, Month 48 and Month 60
| Intervention | LogMar (Mean) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Day 1 | Day7 | Week 3 | Week 6 | Month 3 | Month 6 | Month 9 | Month 12 | Month 24 | Month 36 | Month 48 | Month 60 | |
| MIDI Arrow | .94 | 1.28 | .99 | .87 | .76 | .92 | .85 | .85 | .79 | .90 | .69 | .44 | .43 |
Secondary Effectiveness Endpoint #1 is the mean diurnal change in IOP from Screening at 12 months. (NCT01881425)
Timeframe: 12 months
| Intervention | mmHg (Mean) |
|---|---|
| InnFocus MicroShunt | -6.46 |
| Trabeculectomy | -9.80 |
Secondary Effectiveness Endpoint #1 is the mean diurnal change in IOP from Screening at 24 months (NCT01881425)
Timeframe: 24 months
| Intervention | mmHg (Mean) |
|---|---|
| InnFocus MicroShunt | -6.55 |
| Trabeculectomy | -9.85 |
The primary effectiveness outcome is ≥ 20% reduction in mean diurnal IOP without increasing number of glaucoma medications from baseline to 24 months follow-up (NCT01881425)
Timeframe: 24 months
| Intervention | Participants (Count of Participants) |
|---|---|
| InnFocus MicroShunt | 200 |
| Trabeculectomy | 85 |
The primary effectiveness outcome is ≥ 20% reduction in mean diurnal IOP without increasing number of glaucoma medications from baseline to 12 months follow-up (NCT01881425)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) |
|---|---|
| InnFocus MicroShunt | 216 |
| Trabeculectomy | 96 |
The Secondary Effectiveness Endpoint #2 was having any physical or medical postoperative intervention (other than eye massage) intended to alter IOP by the Month 12 follow-up visit. (NCT01881425)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) |
|---|---|
| InnFocus MicroShunt | 161 |
| Trabeculectomy | 89 |
The Secondary Effectiveness Endpoint #2 was having any physical or medical postoperative intervention (other than eye massage) intended to alter IOP by the Month 24 follow-up visit. (NCT01881425)
Timeframe: 24 months
| Intervention | Participants (Count of Participants) |
|---|---|
| InnFocus MicroShunt | 219 |
| Trabeculectomy | 93 |
Percentage of participants with ocular adverse events and other adverse events as identified by eye examination, physical examination, subject reporting and changes in vital signs one year post-operatively. (NCT00626782)
Timeframe: 12 months
| Intervention | percentage of participants (Number) |
|---|---|
| Treatment 1 (Ranibizumab 0.5mg) | 100 |
| Treatment 2 (Mitomycin C 0.4 mg/ml) | 16.67 |
Mean number of glaucoma medications used by each participant over the course of one year post-operatively. (NCT00626782)
Timeframe: 1 day, 2 wks, 1, 3, 6 and 12 months
| Intervention | number of glaucoma medications used (Mean) | |||||
|---|---|---|---|---|---|---|
| 1 Day | 2 wks | 1 month | 3 months | 6 months | 12 months | |
| A: Ranibizumab 0.5mg (0.05mL) Injection | 0.01 | 0.0 | 0.13 | 0.66 | 0.34 | 0.15 |
| B: Mitomycin C 0.4 mg/ml Sponge | 0.0 | 0.01 | 0.01 | 0.08 | 0.06 | 0.06 |
To assess ocular adverse events of combination ranibizumab and MMC therapy at 6 months (NCT00661583)
Timeframe: 6 months
| Intervention | Number of Reported Adverse Events (Number) |
|---|---|
| Ranibizumab Alone | 0 |
| Ranibizumab and MMC | 0 |
| MMC Alone | 0 |
To determine percent of subjects with a qualified success and viable bleb at 6 months (IOP between 6mm Hg and 22 mm Hg with pressure controlled with and without adjunctive medications) (NCT00661583)
Timeframe: 6 months
| Intervention | percentage of subjects (Number) |
|---|---|
| Ranibizumab Alone | 100 |
| Ranibizumab and MMC | 100 |
| MMC Alone | 100 |
Mean change in in intraocular pressure at 3 months and at 6 months (NCT00661583)
Timeframe: 6 months
| Intervention | mmHg (Mean) | |
|---|---|---|
| month 3 minus baseline | month 6 minus baseline | |
| MMC Alone | -8.35 | -8.00 |
| Ranibizumab Alone | -6.40 | -6.60 |
| Ranibizumab and MMC | -6.40 | -4.90 |
Mean change in visual acuity in logMAR. (NCT00661583)
Timeframe: 6 months
| Intervention | logMAR (Mean) | |
|---|---|---|
| Month 3 minus baseline | Month 6 minus baseline | |
| MMC Alone | 0.13 | 0.13 |
| Ranibizumab Alone | -0.01 | -0.05 |
| Ranibizumab and MMC | 0.01 | 0.05 |
12 reviews available for mitomycin and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Estimation of risk-benefit ratio and comparison of post-operative efficacy results between trabeculectomy and canaloplasty.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Risk Assessmen | 2021 |
[Role of Intraoperative Indirect Channelography in Glaucoma Stent Implantation].
Topics: Administration, Ophthalmic; Aged, 80 and over; Bevacizumab; Combined Modality Therapy; Female; Fluor | 2017 |
Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis.
Topics: Antimetabolites; Databases, Factual; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pr | 2013 |
Efficacy and tolerability of nonpenetrating glaucoma surgery augmented with mitomycin C in treatment of open-angle glaucoma: a meta-analysis.
Topics: Alkylating Agents; Clinical Trials as Topic; Combined Modality Therapy; Databases, Factual; Filterin | 2009 |
Efficacy and tolerability of nonpenetrating filtering surgery in the treatment of open-angle glaucoma: a meta-analysis.
Topics: Combined Modality Therapy; Glaucoma, Open-Angle; Humans; Mitomycin; Postoperative Complications; Ran | 2010 |
Lid retraction following glaucoma filtering surgery: a case series and literature review.
Topics: Aged; Blepharoplasty; Eyelid Diseases; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Mito | 2009 |
Anti--vascular endothelial growth factor therapy in glaucoma filtration surgery.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Filtering Surgery; Fluorouracil; Glaucoma, Open-Angle; H | 2011 |
Systematic overview of the efficacy of nonpenetrating glaucoma surgery in the treatment of open angle glaucoma.
Topics: Filtering Surgery; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin | 2011 |
Trabeculotomy ab externo: an alternative treatment in adult patients with primary open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma, Open | 1993 |
[Current topics in glaucoma].
Topics: Adult; Animals; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; M | 1996 |
Three types of retinal bleeding as a complication of hypotony after trabeculectomy.
Topics: Adolescent; Adult; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glaucoma, Open- | 1999 |
Combined surgery in the treatment of patients with cataract and primary open-angle glaucoma.
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Mitomy | 2001 |
76 trials available for mitomycin and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Long-term effects of intraoperative topical bevacizumab in sutureless scleral tunnel trabeculectomy: a prospective clinical trial.
Topics: Antiglaucoma Agents; Bevacizumab; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Press | 2023 |
Can postoperative dexamethasone nanoparticle eye drops replace mitomycin C in trabeculectomy?
Topics: Aged; Aged, 80 and over; Alkylating Agents; Dexamethasone; Female; Glaucoma, Open-Angle; Glucocortic | 2020 |
Trabeculectomy With Extended Subscleral Tunnel Versus Conventional Trabeculectomy in the Management of POAG: A 1-Year Randomized-controlled Trial.
Topics: Adult; Aged; Antihypertensive Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ma | 2020 |
Intracameral tissue plasminogen activator in trabeculectomy: a 1-year prospective, randomized, controlled study.
Topics: Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mitomycin; Pros | 2020 |
A Randomized Controlled Trial Comparing Subconjunctival Injection to Direct Scleral Application of Mitomycin C in Trabeculectomy.
Topics: Aged; Conjunctiva; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Injections; Intraocular | 2020 |
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie | 2021 |
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie | 2021 |
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie | 2021 |
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie | 2021 |
Efficacy of Trabeculectomy Combined With Limited Deep Sclerectomy Versus Trabeculectomy Alone: A Randomized-controlled Trial.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy; Treatment Out | 2021 |
Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Angiogenesis Inhibitors; Bevacizumab; Double-Blind Metho | 2017 |
Simultaneous use of amniotic membrane and Mitomycin C in trabeculectomy for primary glaucoma.
Topics: Adult; Aged; Alkylating Agents; Amnion; Combined Modality Therapy; Conjunctiva; Female; Glaucoma, Op | 2017 |
The Primary Tube Versus Trabeculectomy Study: Methodology of a Multicenter Randomized Clinical Trial Comparing Tube Shunt Surgery and Trabeculectomy with Mitomycin C.
Topics: Alkylating Agents; Antihypertensive Agents; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans | 2018 |
Comparison of Mean Corneal Endothelial Cell Loss after Trabeculectomy with and without Mitomycin C.
Topics: Aged; Antimetabolites; Corneal Endothelial Cell Loss; Endothelium, Corneal; Female; Glaucoma, Open-A | 2018 |
Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study).
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Double-Blind Method; Female; Glaucoma | 2019 |
Suture Removal After Trabeculectomy With Fornix-based Conjunctival Flap Leads to Faster Visual Recovery but Not Reduced Astigmatism.
Topics: Aged; Alkylating Agents; Astigmatism; Conjunctiva; Female; Follow-Up Studies; Glaucoma, Open-Angle; | 2019 |
Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma.
Topics: Antibiotics, Antineoplastic; Collagen; Drug Implants; Female; Follow-Up Studies; Glaucoma, Open-Angl | 2013 |
Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Topics: Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Co | 2015 |
Trabeculectomy using mitomycin C versus an atelocollagen implant: clinical results of a randomized trial and histopathologic findings.
Topics: Absorbable Implants; Actins; Aged; Alkylating Agents; Collagen; Collagen Type III; Combined Modality | 2014 |
Trabeculectomy With Mitomycin-C Versus Trabeculectomy With Amniotic Membrane Transplant: A Medium-term Randomized, Controlled Trial.
Topics: Aged; Alkylating Agents; Amnion; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; M | 2015 |
Ranibizumab versus mitomycin C in primary trabeculectomy--a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glaucom | 2015 |
Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Double-Blind Method; Female; Follow | 2015 |
Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
Topics: Absorbable Implants; Adult; Aged; Alkylating Agents; Collagen; Exfoliation Syndrome; Female; Follow- | 2016 |
Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions.
Topics: Cataract; Collagen; Combined Modality Therapy; Gels; Glaucoma Drainage Implants; Glaucoma, Open-Angl | 2016 |
Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Bevacizumab; Conjunctiva; Dose-Re | 2017 |
Sutureless Scleral Tunnel Trabeculectomy: Evaluation of Feasibility and Effectiveness versus Conventional Trabeculectomy for Management of Primary Open Angle Glaucoma.
Topics: Aged; Antihypertensive Agents; Feasibility Studies; Female; Glaucoma, Open-Angle; Humans; Intraocula | 2018 |
Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2017 |
Trabeculectomy with Ologen versus Mitomycin C in Juvenile Open-Angle Glaucoma: A 1-Year Study.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Collagen; Female; Follow-Up Studies; Glaucoma, Open- | 2017 |
Nine-year follow-up of trabeculectomy with or without low-dosage mitomycin-c in primary open-angle glaucoma.
Topics: Aged; Antibiotics, Antineoplastic; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocu | 2008 |
Effect of different application depths of mitomycin-C in deep sclerectomy with collagen implant: a randomized controlled trial.
Topics: Absorbable Implants; Aged; Aged, 80 and over; Cicatrix; Collagen; Female; Glaucoma, Open-Angle; Huma | 2009 |
Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study.
Topics: Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Hu | 2010 |
A prospective randomised trial of trabeculectomy using mitomycin C vs an ologen implant in open angle glaucoma.
Topics: Absorbable Implants; Aged; Collagen; Cross-Linking Reagents; Female; Glaucoma Drainage Implants; Gla | 2010 |
CO2 laser-assisted sclerectomy surgery, part II: multicenter clinical preliminary study.
Topics: Adult; Alkylating Agents; Exfoliation Syndrome; Female; Filtering Surgery; Glaucoma, Open-Angle; Hum | 2012 |
Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial.
Topics: Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Ca | 2012 |
Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Chemothe | 2012 |
Purified triamcinolone acetonide as antifibrotic adjunct in glaucoma filtering surgery.
Topics: Aged; Alkylating Agents; Conjunctiva; Female; Fibrosis; Glaucoma, Angle-Closure; Glaucoma, Open-Angl | 2013 |
Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS).
Topics: Antimetabolites; Cataract Extraction; Endophthalmitis; Fluorouracil; Follow-Up Studies; Glaucoma, Op | 2013 |
Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma.
Topics: Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Female; Glaucoma, Open-An | 2002 |
Two-site phacotrabeculectomy with intraoperative mitomycin-C: fornix- versus limbus-based conjunctival opening in fellow eyes.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intr | 2002 |
Five-year follow-up of LSL trabeculectomies with low dosage mitomycin-C in primary open-angle glaucoma.
Topics: Aged; Antimetabolites; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma, Open-Angle; H | 2002 |
A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Glaucoma, Open-Angle; Humans; Hya | 2003 |
A comparative study of small incision trabeculectomy avoiding Tenon's capsule vis-à-vis trabeculectomy with Mitomycin-C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Glaucoma, Open-Angle; H | 2004 |
A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Blister; Cataract; Female; Filtering Surgery; Fluor | 2004 |
[Deep sclerectomy using a hyaluronate implant versus trabeculectomy. A comparison of two glaucoma operations using mitomycin C].
Topics: Adult; Aged; Aged, 80 and over; Descemet Membrane; Female; Filtering Surgery; Follow-Up Studies; Gla | 2004 |
Deep sclerectomy and low dose mitomycin C: a randomised prospective trial in west Africa.
Topics: Adult; Aged; Combined Modality Therapy; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; | 2006 |
A pilot study on slit lamp-adapted optical coherence tomography imaging of trabeculectomy filtering blebs.
Topics: Aged; Alkylating Agents; Aqueous Humor; Blister; Conjunctiva; Diagnostic Techniques, Ophthalmologica | 2007 |
Randomized comparison of the intraocular pressure-lowering effect of phacoviscocanalostomy and phacotrabeculectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Catheterization; Chronic Disease; Female; Glau | 2007 |
Laser suture lysis or releasable sutures after trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Aqueous Humor; Exfoliation Syndrome; Female; Glau | 2007 |
Randomized comparison of 1-Site and 2-Site phacotrabeculectomy with 3-year follow-up.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cataract; Female; Follow-Up Studies; Glaucoma, Ope | 2008 |
Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up.
Topics: Aged; Dose-Response Relationship, Drug; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, O | 2008 |
5-Fluorouracil and mitomycin C in pseudophakic patients.
Topics: Aged; Cataract Extraction; Conjunctiva; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; Intraope | 1995 |
Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma.
Topics: Administration, Topical; Adult; Aged; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma | 1993 |
Intraoperative mitomycin C in complicated glaucomas.
Topics: Adult; Age Factors; Aged; Aphakia; Drug Evaluation; Female; Fluorouracil; Glaucoma; Glaucoma, Open-A | 1993 |
Trabeculotomy ab externo: an alternative treatment in adult patients with primary open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma, Open | 1993 |
[Primary trabeculectomy for open-angle glaucoma with mitomycin C].
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Glaucoma, Open-Angle; Humans; Mal | 1995 |
Subconjunctival versus intrascleral mitomycin-C in trabeculectomy.
Topics: Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Conjunctiva; Drug Administration Routes; Female; Fo | 1996 |
Primary glaucoma triple procedure with or without adjunctive mitomycin. Prognostic factors for filtration failure.
Topics: Aged; Aged, 80 and over; Cataract Extraction; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; | 1996 |
Adjunctive subconjunctival mitomycin C in glaucoma triple procedure.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Conjunctiva; Female; Follow-Up | 1995 |
A long-term dose-response study of mitomycin in glaucoma filtration surgery.
Topics: Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glaucoma | 1997 |
Comparative study of silicone versus acrylic foldable lens implantation in primary glaucoma triple procedure.
Topics: Acrylic Resins; Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lenses, Intraocula | 1997 |
Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C.
Topics: Aged; Cataract; Chemotherapy, Adjuvant; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intraocul | 1998 |
Primary glaucoma triple procedure in patients with primary open-angle glaucoma: the effect of mitomycin C in patients with and without prognostic factors for filtration failure.
Topics: Aged; Cataract; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; Humans; Lens Implantation, Int | 1998 |
The role of adjunctive mitomycin C in secondary glaucoma triple procedure as compared to primary glaucoma triple procedure.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; Humans; Intrao | 1998 |
Risk of hypotony after primary trabeculectomy with antifibrotic agents in a black west African population.
Topics: Fluorouracil; Follow-Up Studies; Ghana; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Intraope | 1998 |
Delayed postoperative use of 5-fluorouracil in primary open angle glaucoma.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Fluorouracil; Follow-Up Studies; Glauc | 1997 |
Decrease of capsular opacification with adjunctive mitomycin C in combined glaucoma and cataract surgery.
Topics: Aged; Aged, 80 and over; Cataract; Cataract Extraction; Chemotherapy, Adjuvant; Female; Glaucoma, Op | 1998 |
The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemotherapy, Adjuvant; Chr | 1998 |
Delayed post-operative use of 5-fluorouracil as an adjunct in medically uncontrolled open angle glaucoma.
Topics: Aged; Aged, 80 and over; Antimetabolites; Chemotherapy, Adjuvant; Drug Administration Schedule; Fema | 1998 |
Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens, Crystalline; Male; Middle Ag | 1998 |
[The clinical effect after locally using mitomycin C during trabeculectomy in glaucoma].
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Child; Female; | 1997 |
Initial trabeculectomy with intraoperative mitomycin-C application in primary glaucomas.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Glaucoma, O | 1999 |
Ab-interno goniotrabeculotomy versus mitomycin C trabeculectomy for adult open-angle glaucoma: a 2-year randomized clinical trial.
Topics: Anterior Chamber; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; | 1999 |
Posterior capsular opacification in phacotrabeculectomy : a long-term comparative study of silicone versus acrylic intraocular lens.
Topics: Acrylic Resins; Adult; Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Female; Follow-Up | 2000 |
Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial.
Topics: Female; Follow-Up Studies; Glaucoma Drainage Implants; Glaucoma, Angle-Closure; Glaucoma, Open-Angle | 2000 |
Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial.
Topics: Female; Follow-Up Studies; Glaucoma Drainage Implants; Glaucoma, Angle-Closure; Glaucoma, Open-Angle | 2000 |
Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial.
Topics: Female; Follow-Up Studies; Glaucoma Drainage Implants; Glaucoma, Angle-Closure; Glaucoma, Open-Angle | 2000 |
Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial.
Topics: Female; Follow-Up Studies; Glaucoma Drainage Implants; Glaucoma, Angle-Closure; Glaucoma, Open-Angle | 2000 |
Indocyanine green anterior segment angiography for studying conjunctival vascular changes after trabeculectomy.
Topics: Adult; Aged; Anterior Eye Segment; Capillary Permeability; Conjunctiva; Female; Fluorescein Angiogra | 2001 |
[A clinical comparative study of interferon alpha-2b with mitomycin C applied in glaucoma filtering operation].
Topics: Adolescent; Adult; Female; Filtering Surgery; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Inter | 2000 |
Laser-assisted deep sclerectomy.
Topics: Adult; Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Male; Middle | 2002 |
A randomised, prospective study comparing trabeculectomy augmented with antimetabolites with a viscocanalostomy technique for the management of open angle glaucoma uncontrolled by medical therapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Combined Modality Therapy; Female; Fluorouracil; Fo | 2002 |
Intraoperative episcleral versus postoperative topical application of mitomycin-C for trabeculectomies.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Ch | 2002 |
233 other studies available for mitomycin and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Comparison of subconjunctival microinvasive glaucoma surgery and trabeculectomy.
Topics: Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Retrospective Stud | 2022 |
Infective Necrotizing Scleritis After XEN Gel Stent With Mitomycin-C.
Topics: Aged; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomy | 2022 |
Acute iris toxicity following bilateral gel stent implantation with mitomycin-C and intracameral moxifloxacin January consultation #1.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Mitomycin; Moxifloxacin; Ref | 2022 |
Does mitomycin-C concentration have any influence on XEN45 gel stent outcomes in a real-world setting?
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Sten | 2022 |
Survey of glaucoma surgical preferences among glaucoma specialists in Spain.
Topics: Collagen; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Spain | 2022 |
Ologen implant versus mitomycin C in combined trabeculectomy and phacoemulsification.
Topics: Alkylating Agents; Collagen; Follow-Up Studies; Glaucoma, Open-Angle; Glycosaminoglycans; Humans; In | 2022 |
Efficacy of ab-interno gelatin microstent implantation in primary and refractory glaucoma.
Topics: Adult; Gelatin; Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pres | 2023 |
Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma?
Topics: Choroidal Effusions; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Myopia | 2022 |
Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.
Topics: Antihypertensive Agents; Cataract; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mit | 2022 |
Early Complications and Results of Preserflo MicroShunt in the Management of Uncontrolled Open-Angle Glaucoma: A Case Series.
Topics: Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mitomycin; Tonometry, Oc | 2022 |
Short-term surgical outcomes of twin-site combined phaco-emulsification and mitomycin-C augmented trabeculectomy in pseudo-exfoliation glaucoma versus primary open-angle glaucoma.
Topics: Aged; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged; Mitomyc | 2022 |
Two-Year Outcomes of Trabeculectomy and Phacotrabeculectomy in Primary Open Angle Versus Primary Angle Closure Glaucoma.
Topics: Glaucoma; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Ph | 2023 |
Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study.
Topics: Cataract; Eye; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Ret | 2023 |
One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma.
Topics: Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Prospective Studies; Treatm | 2023 |
Acute Necrotizing Retinopathy After Xen Gel Stent Implantation.
Topics: Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged; | 2023 |
Treatment Outcomes for Juvenile Open Angle Glaucoma in Thailand.
Topics: Adolescent; Adult; Child; Child, Preschool; Cornea; Female; Follow-Up Studies; Glaucoma; Glaucoma, O | 2023 |
A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient.
Topics: Adult; Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mal | 2023 |
Comparative study of surgical outcomes of twin-site phacotrabeculectomy with mitomycin C in primary open-angle glaucoma versus primary angle-closure glaucoma.
Topics: Antiglaucoma Agents; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mi | 2023 |
Surgical outcomes of trabeculectomy augmented with sub-Tenon injected mitomycin C.
Topics: Follow-Up Studies; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Trabecul | 2023 |
XEN Gel Stent to Treat ICE Syndrome: 4 Cases.
Topics: Adult; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucoma Drainage Implants; Glauco | 2019 |
New superior modified fornix-based twin-site phacotrabeculectomy.
Topics: Antibiotics, Antineoplastic; Cataract; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Mitomy | 2019 |
Efficacy of Needling Revision After XEN Gel Stent Implantation: A Prospective Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Dry Needling; Female; Glaucoma Drainage Implants; | 2020 |
XEN® stent complications: a case series.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Anterior Eye Segment; Aqueous Humor; Glaucoma Drainage I | 2019 |
Comments on: Mid-term outcome of mitomycin C-augmented trabeculectomy in open-angle glaucoma versus angle-closure glaucoma.
Topics: Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Trabeculecto | 2020 |
Response to comments on: Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle-closure glaucoma.
Topics: Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Trabeculecto | 2020 |
Hypotony Keratopathy Following Trabeculectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Corneal Edema; Female; Glaucoma, Open-Angle; Humans; Int | 2020 |
A standardized protocol of laser suture lysis in postoperative management in trabeculectomy with mitomycin C: One-year study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Clinical Protocols; Device Removal; Female; Glaucoma, Op | 2021 |
Comparison of early versus late laser goniopuncture following deep sclerectomy for the management of open-angle glaucoma.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressu | 2020 |
Impact of Phacoemulsification Combined with XEN Gel Stent Implantation on Corneal Endothelial Cell Density: 2-Year Results.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cell Count; Corneal Endothelial Cell Loss; Endothelium, | 2020 |
Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C.
Topics: Aged; Alkylating Agents; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocul | 2020 |
Early Postoperative Intraocular Pressure is Associated With Better Pressure Control After XEN Implantation.
Topics: Adult; Aged; Exfoliation Syndrome; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; | 2020 |
Open angle glaucoma secondary to endogenous cortisone due to pituitary microadenoma in a young patient, a case report.
Topics: ACTH-Secreting Pituitary Adenoma; Adult; Combined Modality Therapy; Cortisone; Diagnostic Techniques | 2020 |
Bleb Plication for a Leaking Bleb After Trabeculectomy.
Topics: Adult; Aged, 80 and over; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; M | 2020 |
Comparing Treatment Outcomes from the Tube Versus Trabeculectomy and Primary Tube Versus Trabeculectomy Studies.
Topics: Aged; Alkylating Agents; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocul | 2021 |
The role of mitomycin C and porcine extracellular matrix in phacotrabeculectomy.
Topics: Adult; Aged; Alkylating Agents; Cataract; Collagen; Drug Combinations; Female; Glaucoma, Open-Angle; | 2021 |
Scheimpflug Corneal Densitometry Changes After Trabeculectomy.
Topics: Aged; Alkylating Agents; Cell Count; Cornea; Densitometry; Female; Follow-Up Studies; Glaucoma, Open | 2021 |
Needling revision with marking maneuver to locate the scleral flap.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Pilot Projects; Prospective Studies; | 2021 |
Comparison of Gonioscopy-assisted Transluminal Trabeculotomy Versus Trabeculectomy With Mitomycin C in Patients With Open-angle Glaucoma.
Topics: Cohort Studies; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; M | 2021 |
Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study.
Topics: Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Tonometry | 2021 |
Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study.
Topics: Follow-Up Studies; Gels; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Press | 2020 |
[Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C].
Topics: Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; | 2021 |
Outcome of repeat trabeculectomy with mitomycin C in isolation or combined with phacoemulsification.
Topics: Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Phacoemulsificatio | 2021 |
Evaluating CO
Topics: Adult; Carbon Dioxide; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lasers; Mitomyc | 2021 |
Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation.
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Trabecul | 2022 |
Outcomes of Glaucoma Drainage Device Implantation and Trabeculectomy With Mitomycin C in Glaucoma Secondary to Aniridia.
Topics: Adolescent; Adult; Alkylating Agents; Aniridia; Cataract Extraction; Child; Child, Preschool; Combin | 2021 |
Trans-conjunctival Erosion of a Novel SIBS Microshunt After Revision Surgery Using Mitomycin C.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Reoperation; Tonometry, Ocular | 2021 |
Anterior-segment optical coherence tomography of filtering blebs in the early postoperative period of ab externo SIBS microshunt implantation with mitomycin C: Morphological analysis and correlation with intraocular pressure reduction.
Topics: Aged; Anterior Eye Segment; Cross-Linking Reagents; Drug Implants; Female; Filtering Surgery; Follow | 2022 |
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study.
Topics: Adolescent; Angiogenesis Inhibitors; Bevacizumab; Follow-Up Studies; Glaucoma, Open-Angle; Humans; I | 2022 |
Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients.
Topics: Cataract; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; | 2021 |
Changes in the morphology of the hyperemic blebs in eyes undergone trabeculectomy with mitomycin C after injection of triamcinolone acetonide during one-year follow-up.
Topics: Conjunctiva; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Mitom | 2021 |
Outcomes of XEN45 gel stent using posterior small incision sub-tenon ab interno insertion (Semi-open) technique.
Topics: Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; | 2022 |
Practice Preferences for Glaucoma Surgery: A Survey of the American Glaucoma Society.
Topics: Alkylating Agents; Cataract; Female; Filtering Surgery; Fluorouracil; Glaucoma Drainage Implants; Gl | 2017 |
Two-year Results After Deep Sclerectomy With Nonabsorbable Uveoscleral Implant (Esnoper-Clip): Surgical Area Analysis Using Anterior Segment Optical Coherence Tomography.
Topics: Aged; Aged, 80 and over; Anterior Eye Segment; Antibiotics, Antineoplastic; Antihypertensive Agents; | 2017 |
The influence of mitomycin C concentration on the outcome of trabeculectomy in uveitic glaucoma.
Topics: Adolescent; Adult; Alkylating Agents; Antihypertensive Agents; Conjunctiva; Female; Glaucoma, Open-A | 2018 |
Prospective evaluation of CO
Topics: Aged; Antibiotics, Antineoplastic; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Incidenc | 2018 |
Short-term change in higher-order aberrations after mitomycin-C-augmented trabeculectomy.
Topics: Antibiotics, Antineoplastic; Cornea; Corneal Topography; Corneal Wavefront Aberration; Female; Follo | 2019 |
Comparison of surgical outcomes between canaloplasty and trabeculectomy with mitomycin C at 2-year follow-up: A longitudinal cohort study.
Topics: Aged; Alkylating Agents; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Incidence; Intraoc | 2018 |
Optical Coherence Tomography Angiography Description of Ocular Decompression Retinopathy After Deep Sclerectomy in Traumatic Glaucoma.
Topics: Alkylating Agents; Decompression, Surgical; Eye Injuries; Fluorescein Angiography; Glaucoma, Open-An | 2018 |
Extensive Submacular Hemorrhage After Trabeculectomy With Mitomycin C.
Topics: Aged; Angiogenesis Inhibitors; Glaucoma, Open-Angle; Humans; Male; Mitomycin; Postoperative Hemorrha | 2018 |
Relationship between age and surgical success after trabeculectomy with adjunctive mitomycin C.
Topics: Administration, Topical; Adolescent; Adult; Age Distribution; Age Factors; Aged; Alkylating Agents; | 2018 |
Trabeculectomy Following Failed Ab Interno Gelatin Microstent: Case Series.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Exfoliation Syndrome; | 2018 |
One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Conjunctiva; Exfoliation Syndro | 2019 |
Trabeculectomy with subconjunctival collagen implant in Indian eyes: Long-term results.
Topics: Adult; Alkylating Agents; Collagen; Conjunctiva; Female; Follow-Up Studies; Glaucoma, Open-Angle; Gl | 2018 |
Smaller-incision Revision of Trabeculectomy With Mitomycin: Long-term Outcomes and Complications.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucom | 2019 |
1-year outcomes of the Xen45 glaucoma implant.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucoma Drainage Implants; Glaucom | 2019 |
Use of a Collagen Matrix Implant as an Adjuvant in Combined Surgery Involving Phacoemulsification and Nonpenetrating Deep Sclerectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Collagen; Exfoliation Syndrome; Female; Glauco | 2019 |
Penetrating deep sclerectomy in primary open-angle and pseudoexfoliative glaucoma.
Topics: Aged; Aged, 80 and over; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intraocular Pre | 2020 |
Bleb Needling with Mitomycin C as Adjunctive Therapy in Failing Blebs: A Retrospective Study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Conjunctival Diseases; Female; Glaucoma, Open-Angle; Hum | 2019 |
Phacotrabeculectomy in Eyes With Uveitic Glaucoma: A Retrospective Case-Control Study.
Topics: Adult; Aged; Case-Control Studies; Combined Modality Therapy; Female; Glaucoma; Glaucoma, Open-Angle | 2019 |
Corneal biomechanical changes after trabeculectomy with mitomycin C in primary open-angle glaucoma and pseudoexfoliation glaucoma.
Topics: Adult; Aged; Biomechanical Phenomena; Cornea; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Hu | 2019 |
Long-term Results of Trabeculectomy With Mitomycin-C in Patients With Bilateral Acute Iris Transillumination.
Topics: Acute Disease; Adult; Aged; Alkylating Agents; Antihypertensive Agents; Conjunctiva; Female; Follow- | 2019 |
Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle closure glaucoma.
Topics: Adult; Aged; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intra | 2019 |
Remodeling an Avascular Bleb.
Topics: Adult; Alkylating Agents; Amnion; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mitomyci | 2019 |
Can intraoperative intraocular pressure during primary trabeculectomy predict early postoperative pressure?
Topics: Adult; Aged; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; In | 2014 |
Using the early postoperative intraocular pressure to predict pressure control after a trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular | 2014 |
Surgical management of secondary glaucoma in Fuchs' heterochromic iridocyclitis.
Topics: Adult; Aged; Alkylating Agents; Female; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; | 2013 |
Can augmented trabeculectomies cause iatrogenic melanoma?
Topics: Alkylating Agents; Chemotherapy, Adjuvant; Conjunctival Neoplasms; Eye Enucleation; Female; Glaucoma | 2014 |
A prospective comparison between trabeculectomy with mitomycin C and phacotrabeculectomy with mitomycin C.
Topics: Aged; Alkylating Agents; Cataract; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intra | 2013 |
Intraindividual comparison of Canaloplasty versus trabeculectomy with mitomycin C in a single-surgeon series.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Catheterization; Exfolia | 2013 |
Secondary glaucoma due to chronic scleritis: trabeculectomy in scleromalacia: a case report.
Topics: Aged; Alkylating Agents; Chronic Disease; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; I | 2014 |
Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cohort Studies; Female; Glaucom | 2014 |
Comparison of Surgical Outcomes Between Phacocanaloplasty and Phacotrabeculectomy at 12 Months' Follow-up: A Longitudinal Cohort Study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; | 2015 |
Blebitis with scleral abscess in a case of operated trabeculectomy with mitomycin C and a subcunjunctival ologen implant.
Topics: Abscess; Alkylating Agents; Anti-Bacterial Agents; Ceftriaxone; Collagen; Drug Therapy, Combination; | 2014 |
Corneal decompensation following bleb needling with 0.01% mitomycin C: a case study.
Topics: Aged; Alkylating Agents; Cataract; Combined Modality Therapy; Conjunctiva; Corneal Edema; Female; Gl | 2014 |
[Evaluation of conjunctival epithelium of filtering blebs by impression cytology].
Topics: Aged; Aged, 80 and over; Aqueous Humor; Blister; Conjunctival Diseases; Conjunctivitis; Cytological | 2014 |
Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction.
Topics: Alkylating Agents; Cataract; Cataract Extraction; Female; Glaucoma, Angle-Closure; Glaucoma, Open-An | 2015 |
Visual improvement following glaucoma surgery: a case report.
Topics: Alkylating Agents; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; Male; Middle Aged | 2014 |
Deep sclerectomy with supraciliary hema implant (Esnoper® V-2000): results and complications.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular | 2015 |
Targeting a low-teen intraocular pressure by trabeculectomy with a fornix-based conjunctival flap: continuous Japanese case series by a single surgeon.
Topics: Adult; Aged; Alkylating Agents; Conjunctiva; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Hum | 2015 |
Histopathological findings of a 1-month-old Ologen implant.
Topics: Absorbable Implants; Alkylating Agents; Collagen; Combined Modality Therapy; Device Removal; Glaucom | 2015 |
Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Cost-Benefit Analysis; Drug Costs; Female; Glaucom | 2015 |
Complications and outcomes of primary phacotrabeculectomy with mitomycin C in a multi-ethnic asian population.
Topics: Aged; Asian People; Cataract; Cataract Extraction; Female; Glaucoma, Angle-Closure; Glaucoma, Open-A | 2015 |
Comparison of Superior Rectus and Peripheral Lamellar Corneal Traction Suture during Trabeculectomy.
Topics: Adult; Antihypertensive Agents; Cornea; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Human | 2016 |
Effect of a Fenestration Between an Intrascleral Lake and Supraciliary Space on Deep Sclerectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Aqueous Humor; Ciliary Body; Combined Modality Th | 2016 |
Antifibrotic effects of pirfenidone on Tenon's fibroblasts in glaucomatous eyes: comparison with mitomycin C and 5-fluorouracil.
Topics: Actins; Adult; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Catara | 2015 |
Endophthalmitis With Corneal Infiltrate After EX-PRESS Glaucoma Drainage Device Implantation.
Topics: Alkylating Agents; Anti-Bacterial Agents; Corneal Diseases; Device Removal; Drug Combinations; Endop | 2016 |
Outcomes of Bleb Revision With Mitomycin C After Ex-PRESS Shunt Surgery.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma Drainage Implants; Glaucoma, Op | 2016 |
Deep Sclerectomy With Mitomycin C and Injectable Cross-linked Hyaluronic Acid Implant: Long-term Results.
Topics: Alkylating Agents; Combined Modality Therapy; Drug Implants; Female; Glaucoma, Open-Angle; Humans; H | 2016 |
Outcomes of Trabeculectomy With Transconjunctival Application Versus Subconjunctival Application of Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Cohort Studies; Combined Modality Therapy; Conjun | 2016 |
Potential Effect of Tumor Necrosis Factor Inhibitors on Trabeculectomy With Mitomycin C for Patients With Juvenile Idiopathic Arthritis-Related Uveitic Glaucoma: A Retrospective Analysis.
Topics: Adolescent; Alkylating Agents; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; | 2015 |
Long-term Outcomes of Mitomycin-C Trabeculectomy in Exfoliative Glaucoma Versus Primary Open-Angle Glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Case-Control Studies; Conjunctiva; Exfoliation Sy | 2017 |
A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Exfoliation Syndrome; F | 2016 |
Three-Year Follow-up of a Novel Aqueous Humor MicroShunt.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Anterior Chamber; Aqueous Humor; Female; Follow-U | 2016 |
Consecutive bilateral decompression retinopathy after mitomycin C trabeculectomy: a case report.
Topics: Cross-Linking Reagents; Decompression; Female; Glaucoma, Open-Angle; Humans; Middle Aged; Mitomycin; | 2016 |
Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies.
Topics: Adult; Aged; Aged, 80 and over; Conjunctival Diseases; Female; Glaucoma; Glaucoma, Open-Angle; Human | 2016 |
Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Exfoliatio | 2016 |
Trabeculectomy with ologen in secondary glaucomas following failed trabeculectomy with MMC: comparative study.
Topics: Alkylating Agents; Collagen; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Glycosaminoglyca | 2016 |
Same-site Trabeculectomy Revision for Failed Trabeculectomy: Outcomes and Risk Factors for Failure.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma, Open-Angle; | 2016 |
Influence of high myopia on outcomes of trabeculectomy with mitomycin C in patients with primary open-angle glaucoma.
Topics: Aged; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Ag | 2016 |
Bleb Morphology After Needling With Viscoelastic of an Ab Interno Microstent Assessed by Optical Coherence Tomography.
Topics: Alkylating Agents; Conjunctiva; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; In | 2017 |
Bimatoprost-induced late-onset choroidal detachment after trabeculectomy: A case report and review of the literature.
Topics: Aged; Antihypertensive Agents; Bimatoprost; Choroid Diseases; Glaucoma, Open-Angle; Humans; Intraocu | 2017 |
Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population.
Topics: Aged; Cataract; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; In | 2017 |
The Influence of Phacoemulsification on Intraocular Pressure Control and Trabeculectomy Survival in Uveitic Glaucoma.
Topics: Adult; Alkylating Agents; Antihypertensive Agents; Case-Control Studies; Cataract; Female; Glaucoma, | 2017 |
Postvitrectomy posturing resulting in contralateral ocular hypotony.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Ocular Hypotension; Pos | 2008 |
Surgical reduction of dysesthetic blebs.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Glaucoma | 2008 |
Corneal endothelial cell loss after mitomycin C-augmented trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Cell Count; Cell Size; Cell Survival; Combined Moda | 2008 |
[Evaluation on the cellular level the filtering bleb following trabeculectomy, using the HRT II Cornea Module].
Topics: Aqueous Humor; Blister; Epithelial Cells; Glaucoma, Open-Angle; Humans; Microscopy, Confocal; Mitomy | 2008 |
Modified deep sclerectomy (D-lectomy MMC) for primary open-angle glaucoma: preliminary results.
Topics: Aged; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; Int | 2009 |
Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study.
Topics: Absorbable Implants; Aged; Anterior Chamber; Choroid Diseases; Collagen; Drug Implants; Exfoliation | 2010 |
Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Blister; Combined Modality Therapy; Education, Medical, Co | 2009 |
Conjunctival characteristics in primary open-angle glaucoma and modifications induced by trabeculectomy with mitomycin C: an in vivo confocal microscopy study.
Topics: Aged; Case-Control Studies; Conjunctiva; Conjunctival Diseases; Female; Glaucoma, Open-Angle; Humans | 2009 |
Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Exfoliation Syndrome; Female; Follow-Up Studies; | 2011 |
Central retinal vein occlusion after nonperforating sclerectomy without mitomycin.
Topics: Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged; Mitomycin; Retinal Vein Occ | 2009 |
Phacotrabeculectomy without mitomycin C in primary angle-closure and open-angle glaucoma.
Topics: Alkylating Agents; Antihypertensive Agents; Cataract; Female; Follow-Up Studies; Glaucoma, Angle-Clo | 2011 |
Application of handheld cautery for reduction of symptomatic circumferential trabeculectomy blebs.
Topics: Aged; Ambulatory Surgical Procedures; Blister; Conjunctival Diseases; Electrocoagulation; Female; Gl | 2010 |
Primary phakic deep sclerectomy augmented with mitomycin C: long-term outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2011 |
Seizures following subconjunctival 5-FU therapy.
Topics: Aged; Alkylating Agents; Antimetabolites; Combined Modality Therapy; Conjunctiva; Fibrosis; Fluorour | 2011 |
Postoperative IOP is related to intrascleral bleb height in eyes with clinically flat blebs following deep sclerectomy with collagen implant and mitomycin.
Topics: Aged; Aged, 80 and over; Blister; Collagen; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressu | 2010 |
[Non-pentrating deep sclerectomy--between safety and efficacy].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antihypertensive Agents; Blister; Drug Therapy, Comb | 2010 |
The prognostic value of the wuerzburg bleb classification score for the outcome of trabeculectomy.
Topics: Antimetabolites; Blister; Combined Modality Therapy; Conjunctiva; Female; Fluorouracil; Follow-Up St | 2011 |
Posterior revision for failed blebs: long-term outcomes.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Stud | 2011 |
Chiasm-compressing rhabdomyosarcoma in a patient presumed to have juvenile-onset open-angle glaucoma.
Topics: Adult; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Magnetic Resonance Imaging; Male; Mitomyc | 2011 |
Trabeculectomy with mitomycin for open-angle glaucoma in phakic vs pseudophakic eyes after phacoemulsification.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Fema | 2011 |
Success rates of trabeculotomy for steroid-induced glaucoma: a comparative, multicenter, retrospective cohort study.
Topics: Adult; Alkylating Agents; Cohort Studies; Female; Glaucoma, Open-Angle; Glucocorticoids; Humans; Int | 2011 |
Different modes of intraocular pressure reduction after three different nonfiltering surgeries and trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pres | 2011 |
MMP expression in leaking filtering blebs and tears after glaucoma filtering surgery.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Blotting, Western; Conjunctiva; Eye Proteins; Female; Fi | 2011 |
Postoperative complications after glaucoma surgery for primary angle-closure glaucoma vs primary open-angle glaucoma.
Topics: Aged; Female; Fluorouracil; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Gonioscopy; Humans; Incid | 2011 |
Central 10-degree visual field change following trabeculectomy in advanced open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antibiotics, Antineoplastic; Female; Glaucoma, | 2011 |
A comparative study of trabeculectomy and the new clear-cornea filtering procedure, intrastromal diathermal keratostomy (IDK).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cornea; Female; Filterin | 2012 |
Effect of trabeculectomy on ocular and corneal higher order aberrations.
Topics: Adult; Aged; Alkylating Agents; Combined Modality Therapy; Cornea; Corneal Topography; Corneal Wavef | 2011 |
Success rates of trabeculotomy for steroid-induced glaucoma: a comparative, multicenter, retrospective cohort study.
Topics: Cohort Studies; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Mitomycin; Mult | 2011 |
Success rates of trabeculotomy for steroid-induced glaucoma: a comparative, multicenter, retrospective cohort study.
Topics: Cohort Studies; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Mitomycin; Mult | 2011 |
Comparison of surgical outcomes between canaloplasty and trabeculectomy at 12 months' follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Filtering Surg | 2011 |
Needling augmented with topical application of mitomycin C for management of bleb failure.
Topics: Administration, Topical; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Fibrosis | 2011 |
Ab interno trabeculectomy versus trabeculectomy for open-angle glaucoma.
Topics: Adult; Antihypertensive Agents; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular | 2012 |
Dramatic dysesthetic overhanging bleb.
Topics: Antibiotics, Antineoplastic; Blister; Combined Modality Therapy; Female; Glaucoma, Open-Angle; Human | 2011 |
Canaloplasty with intraoperative low dosage mitomycin C: a retrospective case series.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Fema | 2013 |
Impact of phacoemulsification on failure of trabeculectomy with mitomycin-C.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Combined Modality Therapy; Exfoliation Synd | 2012 |
Effects of trabeculectomy on posture-induced intraocular pressure changes over time.
Topics: Adult; Aged; Alkylating Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mi | 2012 |
Queries/errors: Trabeculectomy with early/late phacoemulsification.
Topics: Female; Glaucoma, Open-Angle; Humans; Male; Mitomycin; Phacoemulsification; Trabeculectomy | 2012 |
Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study.
Topics: Alkylating Agents; Cataract Extraction; Combined Modality Therapy; Female; Follow-Up Studies; Glauco | 2014 |
Efficacy and safety of deep sclerectomy in childhood glaucoma in Saudi Arabia.
Topics: Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma, Open-Angle; Human | 2014 |
Long-term outcomes of primary trabeculectomy in diabetic patients with primary open angle glaucoma.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Blood Glucose; Case-Control Studies; Diabetes Mell | 2013 |
Long-term filtration and visual field outcomes after primary glaucoma triple procedure with and without mitomycin-C.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans | 2002 |
Subconjunctival injection of autologous platelet concentrate in the treatment of overfiltrating bleb.
Topics: Blood Platelets; Combined Modality Therapy; Conjunctiva; Female; Filtering Surgery; Glaucoma, Open-A | 2003 |
Clinical characteristics and leakage of functioning blebs after trabeculectomy with mitomycin-C in primary glaucoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Aqueous Humor; Combined Mod | 2003 |
[Non-penetrating trabecular surgery with application of mitomycin C].
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Press | 2002 |
Transconjunctival mitomycin-C in needle revisions of failing filtering blebs.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Conjunctiva; Fe | 2003 |
Optical coherence tomography assessment of retinal nerve fiber layer thickness changes after glaucoma surgery.
Topics: Chemotherapy, Adjuvant; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; Interferometry; Intraocu | 2003 |
Correlation between the early morphological appearance of filtering blebs and outcome of trabeculectomy with mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Exfoliation Syndrome; Fem | 2003 |
Outcome of consecutive trabeculectomy.
Topics: Adolescent; Adult; Aged; Antimetabolites; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; Intrao | 2004 |
Hypotonus maculopathy: magnetic resonance appearance.
Topics: Choroid Diseases; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Macula Lutea; Magnetic Resonan | 2004 |
[Postoperative results of non-penetrating trabeculectomy for primary open-angle glaucoma].
Topics: Adult; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Pos | 2004 |
Upper eyelid retraction after glaucoma filtering surgery and topical application of mitomycin C.
Topics: Administration, Topical; Adolescent; Adult; Antibiotics, Antineoplastic; Conjunctiva; Eyelid Disease | 2004 |
Fornix vs limbus based flap in phacotrabeculetomy with mitomycin C: prospective study.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intr | 2004 |
[Non-penetrating deep sclerectomy in the treatment of advanced cases of open angle glaucoma].
Topics: Anti-Bacterial Agents; Female; Glaucoma, Open-Angle; Humans; Hyaluronic Acid; Intraocular Pressure; | 2004 |
[Implication of non-perforating deep sclerectomy with amniotic membrane implantation for primary open-angle glaucoma].
Topics: Adolescent; Adult; Aged; Amnion; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocula | 2002 |
Results of combined phacoemulsification and trabeculectomy with mitomycin C in pseudoexfoliation versus non-pseudoexfoliation glaucoma.
Topics: Aged; Cataract; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intra | 2005 |
Filtering blebs imaging by optical coherence tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Blister; Child; Combined Modality Thera | 2005 |
Risk of sudden visual loss following filtration surgery in end-stage glaucoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Blindness; Female; Follow-Up Studies; Glaucoma, Angle-Clos | 2005 |
Wipe-out: a complication of glaucoma surgery or just a blast from the past?
Topics: Antibiotics, Antineoplastic; Blindness; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intra | 2005 |
Failed trabeculectomy.
Topics: Antimetabolites; Conjunctiva; Fistula; Fluorouracil; Glaucoma Drainage Implants; Glaucoma, Open-Angl | 2005 |
Deep sclerectomy with mitomycin C in failed trabeculectomy.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Chemotherapy, Adjuvant; Drug Administration Schedu | 2007 |
Outcomes of laser suture lysis after initial trabeculectomy with adjunctive mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; Humans; Int | 2006 |
Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Glaucoma, O | 2006 |
The effect of the timing of scleral flap suture release on the safety and long-term success of phacotrabeculectomy.
Topics: Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Glaucoma, Open-Angle; Humans; Lens Im | 2006 |
Incidence of disc hemorrhages in open-angle glaucoma before and after trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Female; Glaucoma, Open-Angle; Humans; Incidence; In | 2006 |
Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Cohort Studies; Combined Modality Therapy; Female; | 2006 |
Risk of sudden visual loss after filtration surgery in end-stage glaucoma.
Topics: Blindness; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; P | 2006 |
Long-term follow-up of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Stud | 2006 |
Intrastromal diathermal keratostomy: a new micropenetrating clear-cornea glaucoma procedure.
Topics: Adult; Aged, 80 and over; Corneal Stroma; Electrocoagulation; Filtering Surgery; Glaucoma, Open-Angl | 2006 |
[Glaucoma with unilateral reddening of the eye].
Topics: Antihypertensive Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Glaucoma, Ope | 2007 |
Use of amniotic membrane as an adjuvant in refractory glaucoma.
Topics: Amnion; Antibiotics, Antineoplastic; Cryopreservation; Glaucoma, Open-Angle; Humans; Intraocular Pre | 2006 |
Early-onset scleral and corneal ectasias following low-dose mitomycin-C-augmented trabeculectomy in a uveitic glaucoma patient.
Topics: Adolescent; Alkylating Agents; Combined Modality Therapy; Corneal Diseases; Dilatation, Pathologic; | 2006 |
Intraocular lens opacification after nonpenetrating glaucoma surgery with mitomycin-C.
Topics: Antibiotics, Antineoplastic; Calcinosis; Calcium Carbonate; Combined Modality Therapy; Device Remova | 2007 |
Management of glaucoma in patients with nanophthalmos.
Topics: Adolescent; Adult; Aged; Cataract Extraction; Eye Abnormalities; Female; Glaucoma, Open-Angle; Human | 2008 |
[Utility of the Visante OCT in the follow-up of glaucoma surgery].
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Conjunctiva; Female; Filtering Surgery; F | 2007 |
Consultation section: cataract surgical problem.
Topics: Anisometropia; Anterior Chamber; Cataract; Choroid Diseases; Combined Modality Therapy; Female; Glau | 2007 |
Trabeculectomy with mitomycin C.
Topics: Alkylating Agents; Combined Modality Therapy; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Le | 2007 |
Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Disease Progression; Female; Follow-Up Studies; G | 2007 |
Amniotic membrane transplantation for intraoperative conjunctival repair during trabeculectomy with mitomycin C.
Topics: Aged; Aged, 80 and over; Amnion; Combined Modality Therapy; Conjunctiva; Exfoliation Syndrome; Eye I | 2007 |
Simultaneous bilateral ocular decompression retinopathy after trabeculectomy with mitomycin C for uveitic glaucoma.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glaucoma, Open | 2008 |
Mitomycin C induces multidrug resistance in glaucoma surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; ATP Binding Cassette Transporter, Sub | 2008 |
Filtering blebs and aqueous pathway an immunocytological and in vivo confocal microscopy study.
Topics: Aged; Aged, 80 and over; Antimetabolites; Aqueous Humor; Cell Count; Chronic Disease; Conjunctiva; E | 2008 |
Medically controlled glaucoma patients show greater increase in intraocular pressure than surgically controlled patients with the water drinking test.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Diagnostic Techniques, | 2008 |
Self-drainage of a posttrabeculectomy choroidal effusion: loss of protective effect.
Topics: Alkylating Agents; Choroid Diseases; Combined Modality Therapy; Exudates and Transudates; Glaucoma, | 2008 |
Flap suture--a simple technique for the revision of hypotony maculopathy following trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma, Open | 2008 |
[Progress in laser sclerotomy ab externo] Enlarging the sclerostomy channel and local mitomycin administration].
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Follow-Up Studies; Glaucoma, Open-Angle; Hum | 1995 |
Adjunctive mitomycin C in primary trabeculectomy in phakic eyes.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; Humans; Incide | 1995 |
The effects of intraoperative mitomycin-C or 5-fluorouracil on glaucoma filtering surgery.
Topics: Adult; Aged; Animals; Filtering Surgery; Fluorouracil; Glaucoma, Angle-Closure; Glaucoma, Open-Angle | 1994 |
Profound long-term hypotony without maculopathy after trabeculectomy with antimetabolite.
Topics: Aged; Female; Fluorescein Angiography; Fluorouracil; Fundus Oculi; Glaucoma, Open-Angle; Humans; Int | 1994 |
Filtering surgery with mitomycin-C in uncomplicated (primary open angle) glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mi | 1994 |
Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery.
Topics: Administration, Topical; Adult; Aged; Cryosurgery; Female; Glaucoma, Open-Angle; Humans; Macula Lute | 1993 |
Use of oversized bandage soft contact lenses in the management of early hypotony following filtration surgery.
Topics: Aged; Aged, 80 and over; Antimetabolites; Contact Lenses, Hydrophilic; Female; Fluorouracil; Follow- | 1996 |
Retinal vein occlusion after trabeculectomy with mitomycin C.
Topics: Aged; Aged, 80 and over; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mitomycin; Postop | 1996 |
Late bleb leakage after trabeculectomy with 5-fluorouracil or mitomycin C.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; Intraocular | 1996 |
Combined phacoemulsification and trabeculectomy with mitomycin-C.
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Follow-Up Studies; Glaucoma, Open-Angle; Hum | 1996 |
Mitomycin-C in laser sclerostomy: benefit and complications.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Follow-Up Studies; Glaucoma, Open-Angle; Human | 1997 |
Severe visual loss after autologous blood injection for mitomycin-C-associated hypotonous maculopathy.
Topics: Adult; Blood; Glaucoma, Open-Angle; Humans; Injections; Intraocular Pressure; Macula Lutea; Male; Mi | 1997 |
[Surgical revision of failed filtering bleb with mitomycin C].
Topics: Adult; Aged; Aged, 80 and over; Female; Filtering Surgery; Fluorouracil; Follow-Up Studies; Glaucoma | 1997 |
Conjunctival impression cytology of the filtering bleb.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Conjunctiva; Epithelium; Female; Follow-Up Studies; Glauco | 1997 |
Corneal blood staining following autologous blood injection for hypotony maculopathy.
Topics: Administration, Topical; Adult; Antibiotics, Antineoplastic; Blood; Cornea; Follow-Up Studies; Glauc | 1997 |
Conditions for balance between lower normal pressure control and hypotony in mitomycin trabeculectomy.
Topics: Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mi | 1998 |
An image analysis study of cataract development after trabeculectomy with mitomycin C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma, Open-Angle; | 1998 |
Primary glaucoma triple procedure in patients with primary open-angle glaucoma.
Topics: Cataract; Cataract Extraction; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens Implantation | 1998 |
Mitomycin C-augumented trabeculectomy with postoperative wound modulation in pediatric glaucoma.
Topics: Adolescent; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fluorouracil; Follow-Up Studies | 1999 |
[A preliminary report of antiscar formation effect by subconjunctival injection of mitomycin C before trabeculectomy in glaucoma].
Topics: Adult; Aged; Alkylating Agents; Cicatrix; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Hum | 1998 |
Antimetabolite use in revising failing filtering blebs.
Topics: Anterior Eye Segment; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Fibrosis; Glaucoma, O | 1999 |
The effect of mitomycin C trabeculectomy on the progression of visual field defect in normal-tension glaucoma.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Disease Progression; Female; Glaucoma, Open-Angle; Humans; Intr | 2000 |
Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 1 intraocular pressure control and complications.
Topics: Aged; Antimetabolites; Chemotherapy, Adjuvant; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; I | 2000 |
[Mitomycin C in open angle glaucoma surgery with previous failed glaucoma surgery].
Topics: Adult; Aged; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Mitomycin; | 2000 |
Short-term effect of mitomycin-C augmented trabeculectomy on axial length and corneal astigmatism.
Topics: Adolescent; Adult; Aged; Anthropometry; Astigmatism; Chemotherapy, Adjuvant; Cornea; Eye; Female; Gl | 2001 |
Management of the failing filter.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Ocular Hypertensio | 2001 |
Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression.
Topics: Aged; Antimetabolites; Chemotherapy, Adjuvant; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; I | 2001 |
Intraoperative mitomycin-C without conjunctival and Tenon's capsule touch in primary trabeculectomy.
Topics: Conjunctiva; Connective Tissue; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intra | 2001 |
[Prognostic outcome of leaking filtering blebs reconstruction with rotational conjunctival flaps].
Topics: Adult; Aged; Antimetabolites; Blister; Combined Modality Therapy; Conjunctival Diseases; Female; Flu | 2001 |
Autologous blood injection for marked overfiltration early after trabeculectomy with mitomycin C.
Topics: Aged; Aged, 80 and over; Aqueous Humor; Blood; Female; Glaucoma, Open-Angle; Humans; Injections; Int | 2001 |
Bilateral chronic hypotony following trabeculectomy with mitomycin-C.
Topics: Adult; Age Factors; Chronic Disease; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mit | 2001 |
Latanoprost-induced iris heterochromia and open-angle glaucoma: a clinicopathologic report.
Topics: Antihypertensive Agents; Diagnosis, Differential; Female; Glaucoma, Open-Angle; Humans; Intraocular | 2001 |
[Application of mitomycin C in glaucoma filtration surgery].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Filtering Surgery; Follow-Up Studies; Glau | 1998 |
Comparison of long-term incidence of posterior capsular opacification between phacoemulsification and phacotrabeculectomy.
Topics: Aged; Antimetabolites; Case-Control Studies; Cataract; Female; Glaucoma, Open-Angle; Humans; Inciden | 2002 |
Corneal endothelial damage after trabeculectomy with mitomycin C in two patients with glaucoma with cornea guttata.
Topics: Adult; Aged; Anterior Chamber; Cell Count; Corneal Diseases; Endothelium, Corneal; Female; Glaucoma, | 2002 |
Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up.
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma, Angle-C | 2002 |